Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Normal Tissue Injury Induced by Photon and Proton Therapies: Gaps and Opportunities.

Normal Tissue Injury Induced by Photon and Proton Therapies: Gaps and Opportunities. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png International journal of radiation oncology, biology, physics Pubmed

Normal Tissue Injury Induced by Photon and Proton Therapies: Gaps and Opportunities.

International journal of radiation oncology, biology, physics , Volume 110 (5): 16 – Sep 23, 2021
Loading next page...
 
/lp/pubmed/normal-tissue-injury-induced-by-photon-and-proton-therapies-gaps-and-NrJZrFHnt0

References (359)

  • Joe Chang, S. Jabbour, D. Ruysscher, S. Schild, C. Simone, R. Rengan, S. Feigenberg, Atif Khan, N. Choi, J. Bradley, X. Zhu, A. Lomax, B. Hoppe (2016)

    Consensus Statement on Proton Therapy in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer.

    International journal of radiation oncology, biology, physics, 95 1

  • Kahalley (2020)

    454

    J Clin Oncol, 38

  • Miszczyk (2015)

    128

    Radiother Oncol, 115

  • C. Grassberger, S. Dowdell, A. Lomax, G. Sharp, J. Shackleford, N. Choi, H. Willers, H. Paganetti (2013)

    Motion interplay as a function of patient parameters and spot size in spot scanning proton therapy for lung cancer.

    International journal of radiation oncology, biology, physics, 86 2

  • (KurtzDM, EsfahaniMS, SchererF, Dynamic risk profiling using serial tumor biomarkers for personalized outcome prediction. Cell 2019;178:699–713.e19.31280963)

    KurtzDM, EsfahaniMS, SchererF,

    KurtzDM, EsfahaniMS, SchererF, Dynamic risk profiling using serial tumor biomarkers for personalized outcome prediction. Cell 2019;178:699–713.e19.31280963, KurtzDM, EsfahaniMS, SchererF, Dynamic risk profiling using serial tumor biomarkers for personalized outcome prediction. Cell 2019;178:699–713.e19.31280963

  • Takatori (2014)

    1074

    J Gastroenterol, 49

  • van Rossum (2020)

    e16

    Pract Radiat Oncol, 10

  • R. Atun, D. Jaffray, M. Barton, F. Bray, M. Baumann, B. Vikram, T. Hanna, F. Knaul, Y. Lievens, Tracey Lui, M. Milosevic, B. O'Sullivan, D. Rodin, E. Rosenblatt, J. Dyk, M. Yap, E. Zubizarreta, M. Gospodarowicz (2015)

    Expanding global access to radiotherapy.

    The Lancet. Oncology, 16 10

  • A. Georgakilas, P. O'Neill, R. Stewart (2013)

    Induction and Repair of Clustered DNA Lesions: What Do We Know So Far?

    , 180

  • S. Girdhani, R. Sachs, L. Hlatky (2013)

    Biological Effects of Proton Radiation: What We Know and Don't Know

    , 179

  • (KahalleyLS, PetersonR, RisMD, Superior intellectual outcomes after proton radiotherapy compared with photon radiotherapy for pediatric medulloblastoma. J Clin Oncol 2020;38:454–461.31774710)

    KahalleyLS, PetersonR, RisMD,

    KahalleyLS, PetersonR, RisMD, Superior intellectual outcomes after proton radiotherapy compared with photon radiotherapy for pediatric medulloblastoma. J Clin Oncol 2020;38:454–461.31774710, KahalleyLS, PetersonR, RisMD, Superior intellectual outcomes after proton radiotherapy compared with photon radiotherapy for pediatric medulloblastoma. J Clin Oncol 2020;38:454–461.31774710

  • Combs (2017)

    12

    Curr Treat Options Neurol, 19

  • Baumann (2016)

    234

    Nature Reviews Cancer, 16

  • (McClellandS3rd, JaboinJJ, WatsonGA, Is the side effect profile of protons really safer than photons for intracranial disease? Clin Neurol Neurosurg 2019;176:8–9.30466016)

    McClellandS3rd, JaboinJJ, WatsonGA,

    McClellandS3rd, JaboinJJ, WatsonGA, Is the side effect profile of protons really safer than photons for intracranial disease? Clin Neurol Neurosurg 2019;176:8–9.30466016, McClellandS3rd, JaboinJJ, WatsonGA, Is the side effect profile of protons really safer than photons for intracranial disease? Clin Neurol Neurosurg 2019;176:8–9.30466016

  • A. Hammi, H. Paganetti, C. Grassberger (2020)

    4D blood flow model for dose calculation to circulating blood and lymphocytes

    Physics in Medicine & Biology, 65

  • Girdhani (2013)

    257

    Radiat Res, 179

  • Jeffrey Straub, J. New, C. Hamilton, C. Lominska, Y. Shnayder, S. Thomas (2015)

    Radiation-induced fibrosis: mechanisms and implications for therapy

    Journal of Cancer Research and Clinical Oncology, 141

  • (BluethmannSM, MariottoAB, RowlandJH. Anticipating the “silver tsunami”: Prevalence trajectories and comorbidity burden among older cancer survivors in the united states. Cancer Epidemiol Biomarkers Prev 2016;25:1029–1036.27371756)

    BluethmannSM, MariottoAB, RowlandJH. Anticipating the ?silver tsunami?: Prevalence trajectories and comorbidity burden among older cancer survivors in the united states. Cancer Epidemiol Biomarkers Prev

    BluethmannSM, MariottoAB, RowlandJH. Anticipating the “silver tsunami”: Prevalence trajectories and comorbidity burden among older cancer survivors in the united states. Cancer Epidemiol Biomarkers Prev 2016;25:1029–1036.27371756, BluethmannSM, MariottoAB, RowlandJH. Anticipating the “silver tsunami”: Prevalence trajectories and comorbidity burden among older cancer survivors in the united states. Cancer Epidemiol Biomarkers Prev 2016;25:1029–1036.27371756

  • S. Mori, A. Knopf, K. Umegaki (2018)

    Motion management in particle therapy

    Medical Physics, 45

  • P. Prasanna, H. Stone, Rosemary Wong, J. Capala, E. Bernhard, B. Vikram, C. Coleman (2012)

    Normal tissue protection for improving radiotherapy: Where are the Gaps?

    Translational cancer research, 1 1

  • Nichols (2015)

    141

    World J Gastrointest Oncol, 7

  • B. Jones (2017)

    Proton radiobiology and its clinical implications

    ecancermedicalscience, 11

  • P. Fang, R. Mick, C. Deville, S. Both, J. Bekelman, J. Christodouleas, Thomas Guzzo, Z. Tochner, S. Hahn, N. Vapiwala (2015)

    A case‐matched study of toxicity outcomes after proton therapy and intensity‐modulated radiation therapy for prostate cancer

    Cancer, 121

  • T. Liamsuwan, S. Uehara, D. Emfietzoglou, H. Nikjoo (2011)

    Physical and biophysical properties of proton tracks of energies 1 keV to 300 MeV in water

    International Journal of Radiation Biology, 87

  • M. Qutub, S. Klein, J. Buchsbaum (2016)

    Rapid RBE-Weighted Proton Radiation Dosimetry Risk Assessment

    Technology in Cancer Research & Treatment, 15

  • M. Mizumoto, T. Okumura, T. Hashimoto, Kuniaki Fukuda, Y. Oshiro, N. Fukumitsu, M. Abei, Atsushi Kawaguchi, Yasutaka Hayashi, A. Ookawa, H. Hashii, Ayae Kanemoto, T. Moritake, E. Tohno, K. Tsuboi, T. Sakae, H. Sakurai (2011)

    Proton beam therapy for hepatocellular carcinoma: a comparison of three treatment protocols.

    International journal of radiation oncology, biology, physics, 81 4

  • (SancarA, Lindsey-BoltzLA, Unsal-KacmazK, Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 2004;73:39–85.15189136)

    SancarA, Lindsey-BoltzLA, Unsal-KacmazK,

    SancarA, Lindsey-BoltzLA, Unsal-KacmazK, Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 2004;73:39–85.15189136, SancarA, Lindsey-BoltzLA, Unsal-KacmazK, Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 2004;73:39–85.15189136

  • B. Venkatesulu, S. Mallick, Steven Lin, S. Krishnan (2018)

    A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors.

    Critical reviews in oncology/hematology, 123

  • M. Baumann, M. Krause, J. Overgaard, J. Debus, S. Bentzen, J. Daartz, C. Richter, D. Zips, T. Bortfeld (2016)

    Radiation oncology in the era of precision medicine

    Nature Reviews Cancer, 16

  • S. Combs (2017)

    Does Proton Therapy Have a Future in CNS Tumors?

    Current Treatment Options in Neurology, 19

  • M. Mishra, S. Aggarwal, S. Bentzen, N. Knight, M. Mehta, W. Regine (2017)

    Establishing Evidence-Based Indications for Proton Therapy: An Overview of Current Clinical Trials.

    International journal of radiation oncology, biology, physics, 97 2

  • D. Goodhead (2006)

    Energy deposition stochastics and track structure: what about the target?

    Radiation protection dosimetry, 122 1-4

  • Mesko (2018)

    76

    Curr Treat Options Oncol, 19

  • Ding (2013)

    372

    BMC Genomics, 14

  • Asaithamby (2011)

    8293

    Proc Natl Acad Sci U S A, 108

  • (KamranSC, LightJO, EfstathiouJA. Proton versus photon-based radiation therapy for prostate cancer: Emerging evidence and considerations in the era of value-based cancer care. Prostate Cancer Prostatic Dis 2019;22:509–521.30967625)

    KamranSC, LightJO, EfstathiouJA. Proton versus photon-based radiation therapy for prostate cancer: Emerging evidence and considerations in the era of value-based cancer care. Prostate Cancer Prostatic Dis

    KamranSC, LightJO, EfstathiouJA. Proton versus photon-based radiation therapy for prostate cancer: Emerging evidence and considerations in the era of value-based cancer care. Prostate Cancer Prostatic Dis 2019;22:509–521.30967625, KamranSC, LightJO, EfstathiouJA. Proton versus photon-based radiation therapy for prostate cancer: Emerging evidence and considerations in the era of value-based cancer care. Prostate Cancer Prostatic Dis 2019;22:509–521.30967625

  • Durante (2016)

    934

    Int J Radiat Oncol Biol Phys, 96

  • Mansoor Ahmed, C. Coleman, M. Mendonca, S. Bentzen, B. Vikram, S. Seltzer, D. Goodhead, C. Obcemea, R. Mohan, K. Prise, J. Capala, D. Citrin, Gary Kao, M. Aryankalayil, I. Eke, J. Buchsbaum, P. Prasanna, Fei-Fei Liu, Q. Le, B. Teicher, D. Kirsch, D. Smart, J. Tepper, S. Formenti, D. Haas-Kogan, D. Raben, James Mitchell (2018)

    Workshop Report for Cancer Research: Defining the Shades of Gy: Utilizing the Biological Consequences of Radiotherapy in the Development of New Treatment Approaches-Meeting Viewpoint.

    Cancer research, 78 9

  • (ChangJY, JabbourSK, De RuysscherD, Consensus statement on proton therapy in early-stage and locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2016;95:505–516.27084663)

    ChangJY, JabbourSK, De RuysscherD,

    ChangJY, JabbourSK, De RuysscherD, Consensus statement on proton therapy in early-stage and locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2016;95:505–516.27084663, ChangJY, JabbourSK, De RuysscherD, Consensus statement on proton therapy in early-stage and locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2016;95:505–516.27084663

  • (KralikSF, MereniukTR, GrignonL, Radiation-induced cerebral microbleeds in pediatric patients with brain tumors treated with proton radiation therapy. Int J Radiat Oncol Biol Phys 2018;102: 1465–1471.30092336)

    KralikSF, MereniukTR, GrignonL,

    KralikSF, MereniukTR, GrignonL, Radiation-induced cerebral microbleeds in pediatric patients with brain tumors treated with proton radiation therapy. Int J Radiat Oncol Biol Phys 2018;102: 1465–1471.30092336, KralikSF, MereniukTR, GrignonL, Radiation-induced cerebral microbleeds in pediatric patients with brain tumors treated with proton radiation therapy. Int J Radiat Oncol Biol Phys 2018;102: 1465–1471.30092336

  • (KralikSF, HoCY, FinkeW, Radiation necrosis in pediatric patients with brain tumors treated with proton radiotherapy. AJNR Am J Neuroradiol 2015;36:1572–1578.26138138)

    KralikSF, HoCY, FinkeW,

    KralikSF, HoCY, FinkeW, Radiation necrosis in pediatric patients with brain tumors treated with proton radiotherapy. AJNR Am J Neuroradiol 2015;36:1572–1578.26138138, KralikSF, HoCY, FinkeW, Radiation necrosis in pediatric patients with brain tumors treated with proton radiotherapy. AJNR Am J Neuroradiol 2015;36:1572–1578.26138138

  • (LiuW, FrankSJ, LiX, Effectiveness of robust optimization in intensity-modulated proton therapy planning for head and neck cancers. Med Phys 2013;40:051711.)

    LiuW, FrankSJ, LiX,

    LiuW, FrankSJ, LiX, Effectiveness of robust optimization in intensity-modulated proton therapy planning for head and neck cancers. Med Phys 2013;40:051711., LiuW, FrankSJ, LiX, Effectiveness of robust optimization in intensity-modulated proton therapy planning for head and neck cancers. Med Phys 2013;40:051711.

  • S. Mesko, D. Gomez (2018)

    Proton Therapy in Non-small Cell Lung Cancer

    Current Treatment Options in Oncology, 19

  • (TaunkNK, HafftyBG, KostisJB, Radiation-induced heart disease: Pathologic abnormalities and putative mechanisms. Front Oncol 2015;5:39.25741474)

    TaunkNK, HafftyBG, KostisJB,

    TaunkNK, HafftyBG, KostisJB, Radiation-induced heart disease: Pathologic abnormalities and putative mechanisms. Front Oncol 2015;5:39.25741474, TaunkNK, HafftyBG, KostisJB, Radiation-induced heart disease: Pathologic abnormalities and putative mechanisms. Front Oncol 2015;5:39.25741474

  • (JakobiA, StutzerK, Bandurska-LuqueA, NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy. Acta Oncol 2015;54:1658–1664.26340301)

    JakobiA, StutzerK, Bandurska-LuqueA,

    JakobiA, StutzerK, Bandurska-LuqueA, NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy. Acta Oncol 2015;54:1658–1664.26340301, JakobiA, StutzerK, Bandurska-LuqueA, NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy. Acta Oncol 2015;54:1658–1664.26340301

  • Sharma (2016)

    627

    Nat Rev Clin Oncol, 13

  • M. Chuong, C. Hallemeier, S. Jabbour, Jen Yu, S. Badiyan, K. Merrell, M. Mishra, Heng Li, V. Verma, Steven Lin (2016)

    Improving Outcomes for Esophageal Cancer using Proton Beam Therapy.

    International journal of radiation oncology, biology, physics, 95 1

  • H. Nikjoo, D. Emfietzoglou, T. Liamsuwan, R. Taleei, D. Liljequist, S. Uehara (2016)

    Radiation track, DNA damage and response—a review

    Reports on Progress in Physics, 79

  • (MacDonaldSM, PatelSA, HickeyS, Proton therapy for breast cancer after mastectomy: Early outcomes of a prospective clinical trial. Int J Radiat Oncol Biol Phys 2013;86:484–490.23523326)

    MacDonaldSM, PatelSA, HickeyS,

    MacDonaldSM, PatelSA, HickeyS, Proton therapy for breast cancer after mastectomy: Early outcomes of a prospective clinical trial. Int J Radiat Oncol Biol Phys 2013;86:484–490.23523326, MacDonaldSM, PatelSA, HickeyS, Proton therapy for breast cancer after mastectomy: Early outcomes of a prospective clinical trial. Int J Radiat Oncol Biol Phys 2013;86:484–490.23523326

  • I. Shuryak, A. Fornace, K. Datta, S. Suman, Santosh Kumar, R. Sachs, D. Brenner (2017)

    Scaling Human Cancer Risks from Low LET to High LET when Dose-Effect Relationships are Complex

    Radiation Research, 187

  • (VeigaC, JanssensG, TengCL, First clinical investigation of cone beam computed tomography and deformable registration for adaptive proton therapy for lung cancer. Int J Radiat Oncol Biol Phys 2016;95:549–559.27084664)

    VeigaC, JanssensG, TengCL,

    VeigaC, JanssensG, TengCL, First clinical investigation of cone beam computed tomography and deformable registration for adaptive proton therapy for lung cancer. Int J Radiat Oncol Biol Phys 2016;95:549–559.27084664, VeigaC, JanssensG, TengCL, First clinical investigation of cone beam computed tomography and deformable registration for adaptive proton therapy for lung cancer. Int J Radiat Oncol Biol Phys 2016;95:549–559.27084664

  • Palayoor (2014)

    1002

    Mol Cancer Res, 12

  • (GoodheadDT. Energy deposition stochastics and track structure: What about the target? Radiat Prot Dosimetry 2006;122:3–15.17276998)

    GoodheadDT. Energy deposition stochastics and track structure: What about the target?

    GoodheadDT. Energy deposition stochastics and track structure: What about the target? Radiat Prot Dosimetry 2006;122:3–15.17276998, GoodheadDT. Energy deposition stochastics and track structure: What about the target? Radiat Prot Dosimetry 2006;122:3–15.17276998

  • B. Hutchins, Kirk Baker, Matthew Davis, Mario Diwersy, Ehsanul Haque, Robert Harriman, Travis Hoppe, Stephen Leicht, P. Meyer, George Santangelo (2019)

    The NIH Open Citation Collection: A public access, broad coverage resource

    PLoS Biology, 17

  • Prasanna (1997)

    594

    Health Phys, 72

  • H. Paganetti (2018)

    Proton Relative Biological Effectiveness – Uncertainties and Opportunities

    , 5

  • H. Nikjoo, S. Uehara, D. Emfietzoglou, L. Pinsky (2011)

    A database of frequency distributions of energy depositions in small-size targets by electrons and ions.

    Radiation protection dosimetry, 143 2-4

  • M. Hall, J. Bradley, R. Rotondo, R. Hanel, C. Shah, C. Morris, P. Aldana, D. Indelicato (2018)

    Risk of Radiation Vasculopathy and Stroke in Pediatric Patients Treated With Proton Therapy for Brain and Skull Base Tumors.

    International journal of radiation oncology, biology, physics, 101 4

  • T. Hong, D. Ryan, D. Borger, L. Blaszkowsky, B. Yeap, M. Ancukiewicz, V. Deshpande, Shweta Shinagare, J. Wo, Y. Boucher, R. Wadlow, E. Kwak, Jill Allen, Jeffrey Clark, A. Zhu, C. Ferrone, H. Mamon, J. Adams, B. Winrich, T. Grillo, R. Jain, T. Delaney, C. Castillo, D. Duda (2014)

    A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinoma.

    International journal of radiation oncology, biology, physics, 89 4

  • Mirsch (2015)

    12396

    Proc Natl Acad Sci U S A, 112

  • (LinSH, HobbsBP, VermaV, Randomized phase IIB trial of proton beam therapy versus intensity-modulated radiation therapy for locally advanced esophageal cancer. J Clin Oncol 2020;38:1569–1579.32160096)

    LinSH, HobbsBP, VermaV,

    LinSH, HobbsBP, VermaV, Randomized phase IIB trial of proton beam therapy versus intensity-modulated radiation therapy for locally advanced esophageal cancer. J Clin Oncol 2020;38:1569–1579.32160096, LinSH, HobbsBP, VermaV, Randomized phase IIB trial of proton beam therapy versus intensity-modulated radiation therapy for locally advanced esophageal cancer. J Clin Oncol 2020;38:1569–1579.32160096

  • Xiang (2020)

    3560

    Cancer, 126

  • Veiga (2016)

    549

    Int J Radiat Oncol Biol Phys, 95

  • Tommasino (2017)

    730

    Acta Oncol, 56

  • A. Knopf, T. Hong, A. Lomax (2011)

    Scanned proton radiotherapy for mobile targets—the effectiveness of re-scanning in the context of different treatment planning approaches and for different motion characteristics

    Physics in Medicine & Biology, 56

  • J. Miszczyk, K. Rawojć, A. Panek, A. Borkowska, P. Prasanna, M.M. Ahmed, J. Swakoń, A. Gałaś (2018)

    Do protons and X-rays induce cell-killing in human peripheral blood lymphocytes by different mechanisms?

    Clinical and Translational Radiation Oncology, 9

  • B. Greenfield, S. Jaramillo, Mirna Abboud, A. Mahajan, A. Paulino, S. McGovern, M. McAleer, M. Chintagumpala, M. Okcu, S. Khatua, Jack Su, D. Grosshans (2016)

    Outcomes for pediatric patients with central nervous system germ cell tumors treated with proton therapy

    Clinical and Translational Radiation Oncology, 1

  • Hirayama (2018)

    3404

    Med Phys, 45

  • J. Schippers, A. Lomax (2011)

    Emerging technologies in proton therapy

    Acta Oncologica, 50

  • (HallMD, BradleyJA, RotondoRL, Risk of radiation vasculopathy and stroke in pediatric patients treated with proton therapy for brain and skull base tumors. Int J Radiat Oncol Biol Phys 2018;101: 854–859.29730064)

    HallMD, BradleyJA, RotondoRL,

    HallMD, BradleyJA, RotondoRL, Risk of radiation vasculopathy and stroke in pediatric patients treated with proton therapy for brain and skull base tumors. Int J Radiat Oncol Biol Phys 2018;101: 854–859.29730064, HallMD, BradleyJA, RotondoRL, Risk of radiation vasculopathy and stroke in pediatric patients treated with proton therapy for brain and skull base tumors. Int J Radiat Oncol Biol Phys 2018;101: 854–859.29730064

  • A. Sancar, L. Lindsey-Boltz, K. Unsal-Kaçmaz, S. Linn (2004)

    Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints.

    Annual review of biochemistry, 73

  • (GreenfieldBJ, JaramilloS, AbboudM, Outcomes for pediatric patients with central nervous system germ cell tumors treated with proton therapy. Clin Transl Radiat Oncol 2016;1:9–14.29657988)

    GreenfieldBJ, JaramilloS, AbboudM,

    GreenfieldBJ, JaramilloS, AbboudM, Outcomes for pediatric patients with central nervous system germ cell tumors treated with proton therapy. Clin Transl Radiat Oncol 2016;1:9–14.29657988, GreenfieldBJ, JaramilloS, AbboudM, Outcomes for pediatric patients with central nervous system germ cell tumors treated with proton therapy. Clin Transl Radiat Oncol 2016;1:9–14.29657988

  • Kurtz (2019)

    699

    Cell, 178

  • (RoutmanDM, GarantA, LesterSC, A comparison of grade 4 lymphopenia with proton versus photon radiation therapy for esophageal cancer. Adv Radiat Oncol 2019;4:63–69.30706012)

    RoutmanDM, GarantA, LesterSC,

    RoutmanDM, GarantA, LesterSC, A comparison of grade 4 lymphopenia with proton versus photon radiation therapy for esophageal cancer. Adv Radiat Oncol 2019;4:63–69.30706012, RoutmanDM, GarantA, LesterSC, A comparison of grade 4 lymphopenia with proton versus photon radiation therapy for esophageal cancer. Adv Radiat Oncol 2019;4:63–69.30706012

  • (McDonaldMW, LiuY, MooreMG, Acute toxicity in comprehensive head and neck radiation for nasopharynx and paranasal sinus cancers: Cohort comparison of 3D conformal proton therapy and intensity modulated radiation therapy. Radiat Oncol 2016;11:32.26922239)

    McDonaldMW, LiuY, MooreMG,

    McDonaldMW, LiuY, MooreMG, Acute toxicity in comprehensive head and neck radiation for nasopharynx and paranasal sinus cancers: Cohort comparison of 3D conformal proton therapy and intensity modulated radiation therapy. Radiat Oncol 2016;11:32.26922239, McDonaldMW, LiuY, MooreMG, Acute toxicity in comprehensive head and neck radiation for nasopharynx and paranasal sinus cancers: Cohort comparison of 3D conformal proton therapy and intensity modulated radiation therapy. Radiat Oncol 2016;11:32.26922239

  • Eaton (2014)

    403

    Cancer J, 20

  • G. Landry, C. Hua (2018)

    Current state and future applications of radiological image guidance for particle therapy

    Medical Physics, 45

  • (BahnE, BauerJ, HarrabiS, Late contrast enhancing brain lesions in proton-treated patients with low-grade glioma: Clinical evidence for increased periventricular sensitivity and variable RBE. Int J Radiat Oncol Biol Phys 2020;107:571–578.32234554)

    BahnE, BauerJ, HarrabiS,

    BahnE, BauerJ, HarrabiS, Late contrast enhancing brain lesions in proton-treated patients with low-grade glioma: Clinical evidence for increased periventricular sensitivity and variable RBE. Int J Radiat Oncol Biol Phys 2020;107:571–578.32234554, BahnE, BauerJ, HarrabiS, Late contrast enhancing brain lesions in proton-treated patients with low-grade glioma: Clinical evidence for increased periventricular sensitivity and variable RBE. Int J Radiat Oncol Biol Phys 2020;107:571–578.32234554

  • (AsaithambyA, HuB, ChenDJ. Unrepaired clustered DNA lesions induce chromosome breakage in human cells. Proc Natl Acad Sci U S A 2011;108:8293–8298.21527720)

    AsaithambyA, HuB, ChenDJ. Unrepaired clustered DNA lesions induce chromosome breakage in human cells. Proc Natl Acad Sci U S A

    AsaithambyA, HuB, ChenDJ. Unrepaired clustered DNA lesions induce chromosome breakage in human cells. Proc Natl Acad Sci U S A 2011;108:8293–8298.21527720, AsaithambyA, HuB, ChenDJ. Unrepaired clustered DNA lesions induce chromosome breakage in human cells. Proc Natl Acad Sci U S A 2011;108:8293–8298.21527720

  • (FangP, ShiraishiY, VermaV, Lymphocyte-sparing effect of proton therapy in patients with esophageal cancer treated with definitive chemoradiation. Int J Part Ther 2018;4:23–32.30079369)

    FangP, ShiraishiY, VermaV,

    FangP, ShiraishiY, VermaV, Lymphocyte-sparing effect of proton therapy in patients with esophageal cancer treated with definitive chemoradiation. Int J Part Ther 2018;4:23–32.30079369, FangP, ShiraishiY, VermaV, Lymphocyte-sparing effect of proton therapy in patients with esophageal cancer treated with definitive chemoradiation. Int J Part Ther 2018;4:23–32.30079369

  • (IndelicatoDJ, FlampouriS, RotondoRL, Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy. Acta Oncol 2014;53:1298–1304.25279957)

    IndelicatoDJ, FlampouriS, RotondoRL,

    IndelicatoDJ, FlampouriS, RotondoRL, Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy. Acta Oncol 2014;53:1298–1304.25279957, IndelicatoDJ, FlampouriS, RotondoRL, Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy. Acta Oncol 2014;53:1298–1304.25279957

  • Dasu (2018)

    81

    Phys Med, 52

  • A. Yock, R. Mohan, S. Flampouri, W. Bosch, P. Taylor, D. Gladstone, Siyong Kim, J. Sohn, R. Wallace, Ying Xiao, J. Buchsbaum (2019)

    Robustness Analysis for External Beam Radiation Therapy Treatment Plans: Describing Uncertainty Scenarios and Reporting Their Dosimetric Consequences.

    Practical radiation oncology, 9 4

  • Lisa Kahalley, R. Peterson, M. Ris, L. Janzen, M. Okcu, D. Grosshans, V. Ramaswamy, A. Paulino, D. Hodgson, A. Mahajan, D. Tsang, N. Laperriere, W. Whitehead, R. Dauser, Michael Taylor, H. Conklin, M. Chintagumpala, E. Bouffet, D. Mabbott (2019)

    Superior Intellectual Outcomes After Proton Radiotherapy Compared With Photon Radiotherapy for Pediatric Medulloblastoma.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology

  • S. Bluethmann, A. Mariotto, J. Rowland (2016)

    Anticipating the “Silver Tsunami”: Prevalence Trajectories and Comorbidity Burden among Older Cancer Survivors in the United States

    Cancer Epidemiology, Biomarkers & Prevention, 25

  • S. Hirayama, T. Matsuura, H. Ueda, Y. Fujii, T. Fujii, S. Takao, N. Miyamoto, S. Shimizu, R. Fujimoto, K. Umegaki, H. Shirato (2018)

    An analytical dose‐averaged LET calculation algorithm considering the off‐axis LET enhancement by secondary protons for spot‐scanning proton therapy

    Medical Physics, 45

  • (KnopfAC, HongTS, LomaxA. Scanned proton radiotherapy for mobile targets-the effectiveness of re-scanning in the context of different treatment planning approaches and for different motion characteristics. Phys Med Biol 2011;56:7257–7271.22037710)

    KnopfAC, HongTS, LomaxA. Scanned proton radiotherapy for mobile targets-the effectiveness of re-scanning in the context of different treatment planning approaches and for different motion characteristics. Phys Med Biol

    KnopfAC, HongTS, LomaxA. Scanned proton radiotherapy for mobile targets-the effectiveness of re-scanning in the context of different treatment planning approaches and for different motion characteristics. Phys Med Biol 2011;56:7257–7271.22037710, KnopfAC, HongTS, LomaxA. Scanned proton radiotherapy for mobile targets-the effectiveness of re-scanning in the context of different treatment planning approaches and for different motion characteristics. Phys Med Biol 2011;56:7257–7271.22037710

  • Kralik (2015)

    1572

    AJNR Am J Neuroradiol, 36

  • Goodhead (2006)

    3

    Radiat Prot Dosimetry, 122

  • S. Kamran, J. Light, J. Efstathiou (2019)

    Proton versus photon-based radiation therapy for prostate cancer: emerging evidence and considerations in the era of value-based cancer care

    Prostate Cancer and Prostatic Diseases

  • Steven Lin, R. Komaki, Z. Liao, Caimiao Wei, B. Myles, Xiaomao Guo, M. Palmer, R. Mohan, S. Swisher, W. Hofstetter, J. Ajani, J. Cox (2012)

    Proton beam therapy and concurrent chemotherapy for esophageal cancer.

    International journal of radiation oncology, biology, physics, 83 3

  • Lin (2020)

    1569

    J Clin Oncol, 38

  • A. Bolsi, L. Placidi, A. Pica, F. Ahllhelm, M. Walser, T. Lomax, D. Weber (2020)

    Pencil beam scanning proton therapy for the treatment of craniopharyngioma complicated with radiation-induced cerebral vasculopathies: a dosimetric and linear energy transfer (LET) evaluation.

    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

  • Stick (2017)

    754

    Int J Radiat Oncol Biol Phys, 97

  • Kento Takatori, K. Terashima, Rihito Yoshida, Aya Horai, S. Satake, T. Ose, N. Kitajima, Y. Kinoshita, Y. Demizu, N. Fuwa (2014)

    Upper gastrointestinal complications associated with gemcitabine-concurrent proton radiotherapy for inoperable pancreatic cancer

    Journal of Gastroenterology, 49

  • (GondiV, YockTI, MehtaMP. Proton therapy for paediatric CNS tumours - Improving treatment-related outcomes. Nat Rev Neurol 2016;12:334–345.27197578)

    GondiV, YockTI, MehtaMP. Proton therapy for paediatric CNS tumours - Improving treatment-related outcomes. Nat Rev Neurol

    GondiV, YockTI, MehtaMP. Proton therapy for paediatric CNS tumours - Improving treatment-related outcomes. Nat Rev Neurol 2016;12:334–345.27197578, GondiV, YockTI, MehtaMP. Proton therapy for paediatric CNS tumours - Improving treatment-related outcomes. Nat Rev Neurol 2016;12:334–345.27197578

  • S. Darby, M. Ewertz, P. Mcgale, A. Bennet, U. Blom-Goldman, D. Brønnum, C. Correa, D. Cutter, G. Gagliardi, B. Gigante, M. Jensen, A. Nisbet, R. Peto, K. Rahimi, Carolyn Taylor, P. Hall (2013)

    Risk of ischemic heart disease in women after radiotherapy for breast cancer.

    The New England journal of medicine, 368 11

  • K. Terashima, Y. Demizu, N. Hashimoto, D. Jin, M. Mima, O. Fujii, Y. Niwa, Kento Takatori, N. Kitajima, Sachiyo Sirakawa, Ku Yonson, Y. Hishikawa, M. Abe, R. Sasaki, K. Sugimura, M. Murakami (2012)

    A phase I/II study of gemcitabine-concurrent proton radiotherapy for locally advanced pancreatic cancer without distant metastasis.

    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 103 1

  • S. Ge, Xiaochun Wang, Z. Liao, L. Zhang, N. Sahoo, Jinzhong Yang, F. Guan, R. Mohan (2019)

    Potential for Improvements in Robustness and Optimality of Intensity-Modulated Proton Therapy for Lung Cancer with 4-Dimensional Robust Optimization

    Cancers, 11

  • M. Durante, D. Brenner, S. Formenti (2016)

    Does Heavy Ion Therapy Work Through the Immune System?

    International journal of radiation oncology, biology, physics, 96 5

  • W. Liu, R. Mohan, X. Zhu, D. Grosshans (2013)

    TH-C-144-04: Robust Optimization in Intensity-Modulated Proton Therapy for Base-Of-Skull Cancers.

    Medical physics, 40 6Part33

  • D. Kurtz, M. Esfahani, F. Scherer, Joanne Soo, Ash Alizadeh (2019)

    Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction

    Cell, 178

  • (ChangJY, ZhangX, KnopfA, Consensus guidelines for implementing pencil-beam scanning proton therapy for thoracic malignancies on behalf of the PTCOG thoracic and Lymphoma subcommittee. Int J Radiat Oncol Biol Phys 2017;99:41–50.28816159)

    ChangJY, ZhangX, KnopfA,

    ChangJY, ZhangX, KnopfA, Consensus guidelines for implementing pencil-beam scanning proton therapy for thoracic malignancies on behalf of the PTCOG thoracic and Lymphoma subcommittee. Int J Radiat Oncol Biol Phys 2017;99:41–50.28816159, ChangJY, ZhangX, KnopfA, Consensus guidelines for implementing pencil-beam scanning proton therapy for thoracic malignancies on behalf of the PTCOG thoracic and Lymphoma subcommittee. Int J Radiat Oncol Biol Phys 2017;99:41–50.28816159

  • (NikjooH, EmfietzoglouD, LiamsuwanT, Radiation track, DNA damage and response-A review. Rep Prog Phys 2016;79: 116601.)

    NikjooH, EmfietzoglouD, LiamsuwanT,

    NikjooH, EmfietzoglouD, LiamsuwanT, Radiation track, DNA damage and response-A review. Rep Prog Phys 2016;79: 116601., NikjooH, EmfietzoglouD, LiamsuwanT, Radiation track, DNA damage and response-A review. Rep Prog Phys 2016;79: 116601.

  • Haas-Kogan (2018)

    152

    Int J Radiat Oncol Biol Phys, 101

  • (WeiL, ShangH, JinF, Mitigation of the interplay effects of combining 4D robust with layer repainting techniques in proton-based sbrt for patients with early-stage non-small cell lung cancer. Front Oncol 2020;10:574605.33163404)

    WeiL, ShangH, JinF,

    WeiL, ShangH, JinF, Mitigation of the interplay effects of combining 4D robust with layer repainting techniques in proton-based sbrt for patients with early-stage non-small cell lung cancer. Front Oncol 2020;10:574605.33163404, WeiL, ShangH, JinF, Mitigation of the interplay effects of combining 4D robust with layer repainting techniques in proton-based sbrt for patients with early-stage non-small cell lung cancer. Front Oncol 2020;10:574605.33163404

  • Greenfield (2016)

    9

    Clin Transl Radiat Oncol, 1

  • (LandryG, HuaCH. Current state and future applications of radiological image guidance for particle therapy. Med Phys 2018;45: e1086–e1095.30421805)

    LandryG, HuaCH. Current state and future applications of radiological image guidance for particle therapy. Med Phys

    LandryG, HuaCH. Current state and future applications of radiological image guidance for particle therapy. Med Phys 2018;45: e1086–e1095.30421805, LandryG, HuaCH. Current state and future applications of radiological image guidance for particle therapy. Med Phys 2018;45: e1086–e1095.30421805

  • Brodin (2014)

    594

    Neuro Oncol, 16

  • Fang (2018)

    23

    Int J Part Ther, 4

  • R. Kabarriti, N. Brodin, Sadia Ahmed, I. Vogelius, C. Guha, S. Kalnicki, W. Tomé, M. Garg (2019)

    Origin of Locoregional Recurrences After Definitive Intensity-modulated Radiation Therapy (IMRT) for Laryngeal Cancer Determined Based on Follow-up PET/CT Imaging

    Cureus, 11

  • Grassberger (2013)

    380

    Int J Radiat Oncol Biol Phys, 86

  • P. Lambin, R. Lieverse, F. Eckert, D. Marcus, C. Oberije, A. Wiel, C. Guha, L. Dubois, J. Deasy (2020)

    Lymphocyte-Sparing Radiotherapy: The Rationale for Protecting Lymphocyte-rich Organs When Combining Radiotherapy With Immunotherapy.

    Seminars in radiation oncology, 30 2

  • Hong (2014)

    830

    Int J Radiat Oncol Biol Phys, 89

  • D. Routman, A. Garant, S. Lester, C. Day, W. Harmsen, Cristobal Sanheuza, H. Yoon, M. Neben-Wittich, J. Martenson, M. Haddock, C. Hallemeier, K. Merrell (2019)

    A Comparison of Grade 4 Lymphopenia With Proton Versus Photon Radiation Therapy for Esophageal Cancer

    Advances in Radiation Oncology, 4

  • Hoppe (2014)

    1076

    Cancer, 120

  • A. Asaithamby, Burong Hu, David Chen (2011)

    Unrepaired clustered DNA lesions induce chromosome breakage in human cells

    Proceedings of the National Academy of Sciences, 108

  • J. Thariat, J. Hannoun-levi, A. Myint, T. Vuong, J. Gérard (2013)

    Past, present, and future of radiotherapy for the benefit of patients

    Nature Reviews Clinical Oncology, 10

  • (DingLH, ParkS, PeytonM, Distinct transcriptome profiles identified in normal human bronchial epithelial cells after exposure to gamma-rays and different elemental particles of high z and energy. BMC Genomics 2013;14:372.23724988)

    DingLH, ParkS, PeytonM,

    DingLH, ParkS, PeytonM, Distinct transcriptome profiles identified in normal human bronchial epithelial cells after exposure to gamma-rays and different elemental particles of high z and energy. BMC Genomics 2013;14:372.23724988, DingLH, ParkS, PeytonM, Distinct transcriptome profiles identified in normal human bronchial epithelial cells after exposure to gamma-rays and different elemental particles of high z and energy. BMC Genomics 2013;14:372.23724988

  • J. Pugh, Alona Sukhina, T. Seed, N. Manley, G. Sempowski, M. Brink, M. Smithey, J. Nikolich-Žugich (2014)

    Histone Deacetylation Critically Determines T Cell Subset Radiosensitivity

    The Journal of Immunology, 193

  • (YockAD, MohanR, FlampouriS, Robustness analysis for external beam radiotherapy treatment plans: Describing uncertainty scenarios and reporting their dosimetric consequences. Pract Radiat Oncol 2019;9:200–207.30562614)

    YockAD, MohanR, FlampouriS,

    YockAD, MohanR, FlampouriS, Robustness analysis for external beam radiotherapy treatment plans: Describing uncertainty scenarios and reporting their dosimetric consequences. Pract Radiat Oncol 2019;9:200–207.30562614, YockAD, MohanR, FlampouriS, Robustness analysis for external beam radiotherapy treatment plans: Describing uncertainty scenarios and reporting their dosimetric consequences. Pract Radiat Oncol 2019;9:200–207.30562614

  • Ariungerel Gerelchuluun, Z. Hong, Lue Sun, Kenshi Suzuki, T. Terunuma, K. Yasuoka, T. Sakae, T. Moritake, K. Tsuboi (2011)

    Induction of in situ DNA double-strand breaks and apoptosis by 200 MeV protons and 10 MV X-rays in human tumour cell lines

    International Journal of Radiation Biology, 87

  • (XiangM, ChangDT, PollomEL. Second cancer risk after primary cancer treatment with three-dimensional conformal, intensity-modulated, or proton beam radiation therapy. Cancer 2020;126:3560–3568.32426866)

    XiangM, ChangDT, PollomEL. Second cancer risk after primary cancer treatment with three-dimensional conformal, intensity-modulated, or proton beam radiation therapy. Cancer

    XiangM, ChangDT, PollomEL. Second cancer risk after primary cancer treatment with three-dimensional conformal, intensity-modulated, or proton beam radiation therapy. Cancer 2020;126:3560–3568.32426866, XiangM, ChangDT, PollomEL. Second cancer risk after primary cancer treatment with three-dimensional conformal, intensity-modulated, or proton beam radiation therapy. Cancer 2020;126:3560–3568.32426866

  • (PrasannaPG, KolankoCJ, GerstenbergHM, Premature chromosome condensation assay for biodosimetry: Studies with fission-neutrons. Health Phys 1997;72:594–600.9119684)

    PrasannaPG, KolankoCJ, GerstenbergHM,

    PrasannaPG, KolankoCJ, GerstenbergHM, Premature chromosome condensation assay for biodosimetry: Studies with fission-neutrons. Health Phys 1997;72:594–600.9119684, PrasannaPG, KolankoCJ, GerstenbergHM, Premature chromosome condensation assay for biodosimetry: Studies with fission-neutrons. Health Phys 1997;72:594–600.9119684

  • (MiszczykJ, RawojcK, PanekA, Do protons and x-rays induce cell-killing in human peripheral blood lymphocytes by different mechanisms? Clin Transl Radiat Oncol 2018;9:23–29.29594247)

    MiszczykJ, RawojcK, PanekA,

    MiszczykJ, RawojcK, PanekA, Do protons and x-rays induce cell-killing in human peripheral blood lymphocytes by different mechanisms? Clin Transl Radiat Oncol 2018;9:23–29.29594247, MiszczykJ, RawojcK, PanekA, Do protons and x-rays induce cell-killing in human peripheral blood lymphocytes by different mechanisms? Clin Transl Radiat Oncol 2018;9:23–29.29594247

  • Georgakilas (2013)

    100

    Radiat Res, 180

  • (LinSH, KomakiR, LiaoZ, Proton beam therapy and concurrent chemotherapy for esophageal cancer. Int J Radiat Oncol Biol Phys 2012;83:e345–e351.22417808)

    LinSH, KomakiR, LiaoZ,

    LinSH, KomakiR, LiaoZ, Proton beam therapy and concurrent chemotherapy for esophageal cancer. Int J Radiat Oncol Biol Phys 2012;83:e345–e351.22417808, LinSH, KomakiR, LiaoZ, Proton beam therapy and concurrent chemotherapy for esophageal cancer. Int J Radiat Oncol Biol Phys 2012;83:e345–e351.22417808

  • (AtunR, JaffrayDA, BartonMB, Expanding global access to radiotherapy. Lancet Oncol 2015;16:1153–1186.26419354)

    AtunR, JaffrayDA, BartonMB,

    AtunR, JaffrayDA, BartonMB, Expanding global access to radiotherapy. Lancet Oncol 2015;16:1153–1186.26419354, AtunR, JaffrayDA, BartonMB, Expanding global access to radiotherapy. Lancet Oncol 2015;16:1153–1186.26419354

  • (LomaxAJ. Intensity modulated proton therapy and its sensitivity to treatment uncertainties 2: The potential effects of inter-fraction and inter-field motions. Phys Med Biol 2008;53:1043–1056.18263957)

    LomaxAJ. Intensity modulated proton therapy and its sensitivity to treatment uncertainties 2: The potential effects of inter-fraction and inter-field motions. Phys Med Biol

    LomaxAJ. Intensity modulated proton therapy and its sensitivity to treatment uncertainties 2: The potential effects of inter-fraction and inter-field motions. Phys Med Biol 2008;53:1043–1056.18263957, LomaxAJ. Intensity modulated proton therapy and its sensitivity to treatment uncertainties 2: The potential effects of inter-fraction and inter-field motions. Phys Med Biol 2008;53:1043–1056.18263957

  • Z. Liao, J. Lee, R. Komaki, Daniel Gomez, Michael O'Reilly, F. Fossella, G. Blumenschein, J. Heymach, A. Vaporciyan, S. Swisher, Pamela Allen, Noah Choi, Thomas DeLaney, Stephen Hahn, James Cox, Charles Lu, R. Mohan (2018)

    Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 36 18

  • P. Fang, Y. Shiraishi, V. Verma, Wen Jiang, Juhee Song, B. Hobbs, Steven Lin (2017)

    Lymphocyte-Sparing Effect of Proton Therapy in Patients with Esophageal Cancer Treated with Definitive Chemoradiation.

    International journal of particle therapy, 4 3

  • Lambin (2020)

    187

    Semin Radiat Oncol, 30

  • (ThompsonRF, MayekarSU, ZhaiH, A dosimetric comparison of proton and photon therapy in unresectable cancers of the head of pancreas. Med Phys 2014;41:081711.)

    ThompsonRF, MayekarSU, ZhaiH,

    ThompsonRF, MayekarSU, ZhaiH, A dosimetric comparison of proton and photon therapy in unresectable cancers of the head of pancreas. Med Phys 2014;41:081711., ThompsonRF, MayekarSU, ZhaiH, A dosimetric comparison of proton and photon therapy in unresectable cancers of the head of pancreas. Med Phys 2014;41:081711.

  • L. Ding, Seongmi Park, M. Peyton, L. Girard, Yang Xie, J. Minna, M. Story (2013)

    Distinct transcriptome profiles identified in normal human bronchial epithelial cells after exposure to γ-rays and different elemental particles of high Z and energy

    BMC Genomics, 14

  • Liu (2016)

    523

    Int J Radiat Oncol Biol Phys, 95

  • Venkatesulu (2018)

    42

    Crit Rev Oncol Hematol, 123

  • P. Prasanna, C. Kolanko, H. Gerstenberg, W. Blakely (1997)

    Premature chromosome condensation assay for biodosimetry: studies with fission-neutrons.

    Health physics, 72 4

  • R. Mohan, K. Held, M. Story, D. Grosshans, J. Capala (2017)

    Proceedings of the National Cancer Institute Workshop on Charged Particle Radiobiology.

    International journal of radiation oncology, biology, physics, 100 4

  • (DasuA, FlejmerAM, EdvardssonA, Normal tissue sparing potential of scanned proton beams with and without respiratory gating for the treatment of internal mammary nodes in breast cancer radiotherapy. Phys Med 2018;52:81–85.30139613)

    DasuA, FlejmerAM, EdvardssonA,

    DasuA, FlejmerAM, EdvardssonA, Normal tissue sparing potential of scanned proton beams with and without respiratory gating for the treatment of internal mammary nodes in breast cancer radiotherapy. Phys Med 2018;52:81–85.30139613, DasuA, FlejmerAM, EdvardssonA, Normal tissue sparing potential of scanned proton beams with and without respiratory gating for the treatment of internal mammary nodes in breast cancer radiotherapy. Phys Med 2018;52:81–85.30139613

  • Steven Lin, B. Hobbs, V. Verma, R. Tidwell, Grace Smith, X. Lei, E. Corsini, Isabel Mok, Xiong Wei, L. Yao, Xin Wang, R. Komaki, Joe Chang, S. Chun, M. Jeter, S. Swisher, J. Ajani, Mariela Blum-Murphy, A. Vaporciyan, R. Mehran, A. Koong, S. Gandhi, W. Hofstetter, T. Hong, T. Delaney, Z. Liao, R. Mohan (2020)

    Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology

  • M. McDonald, Yuan Liu, M. Moore, P. Johnstone (2016)

    Acute toxicity in comprehensive head and neck radiation for nasopharynx and paranasal sinus cancers: cohort comparison of 3D conformal proton therapy and intensity modulated radiation therapy

    Radiation Oncology (London, England), 11

  • Ntentas (2019)

    179

    Pract Radiat Oncol, 9

  • (JonesB. Proton radiobiology and its clinical implications. Ecancermedicalscience 2017;11:777.29104614)

    JonesB. Proton radiobiology and its clinical implications. Ecancermedicalscience

    JonesB. Proton radiobiology and its clinical implications. Ecancermedicalscience 2017;11:777.29104614, JonesB. Proton radiobiology and its clinical implications. Ecancermedicalscience 2017;11:777.29104614

  • Nichols (2013)

    498

    Acta Oncol, 52

  • V. Gondi, T. Yock, M. Mehta (2016)

    Proton therapy for paediatric CNS tumours — improving treatment-related outcomes

    Nature Reviews Neurology, 12

  • (CombsSE. Does proton therapy have a future in CNS tumors? Curr Treat Options Neurol 2017;19:12.28365895)

    CombsSE. Does proton therapy have a future in CNS tumors?

    CombsSE. Does proton therapy have a future in CNS tumors? Curr Treat Options Neurol 2017;19:12.28365895, CombsSE. Does proton therapy have a future in CNS tumors? Curr Treat Options Neurol 2017;19:12.28365895

  • Schippers (2011)

    838

    Acta Oncol, 50

  • (MizumotoM, OkumuraT, HashimotoT, Proton beam therapy for hepatocellular carcinoma: A comparison of three treatment protocols. Int J Radiat Oncol Biol Phys 2011;81:1039–1045.20888707)

    MizumotoM, OkumuraT, HashimotoT,

    MizumotoM, OkumuraT, HashimotoT, Proton beam therapy for hepatocellular carcinoma: A comparison of three treatment protocols. Int J Radiat Oncol Biol Phys 2011;81:1039–1045.20888707, MizumotoM, OkumuraT, HashimotoT, Proton beam therapy for hepatocellular carcinoma: A comparison of three treatment protocols. Int J Radiat Oncol Biol Phys 2011;81:1039–1045.20888707

  • (TakatoriK, TerashimaK, YoshidaR, Upper gastrointestinal complications associated with gemcitabine-concurrent proton radiotherapy for inoperable pancreatic cancer. J Gastroenterol 2014;49: 1074–1080.23846547)

    TakatoriK, TerashimaK, YoshidaR,

    TakatoriK, TerashimaK, YoshidaR, Upper gastrointestinal complications associated with gemcitabine-concurrent proton radiotherapy for inoperable pancreatic cancer. J Gastroenterol 2014;49: 1074–1080.23846547, TakatoriK, TerashimaK, YoshidaR, Upper gastrointestinal complications associated with gemcitabine-concurrent proton radiotherapy for inoperable pancreatic cancer. J Gastroenterol 2014;49: 1074–1080.23846547

  • (BolsiA, PlacidiL, PicaA, Pencil beam scanning proton therapy for the treatment of craniopharyngioma complicated with radiation-induced cerebral vasculopathies: A dosimetric and linear energy transfer (LET) evaluation. Radiother Oncol 2020;149:197–204.32387488)

    BolsiA, PlacidiL, PicaA,

    BolsiA, PlacidiL, PicaA, Pencil beam scanning proton therapy for the treatment of craniopharyngioma complicated with radiation-induced cerebral vasculopathies: A dosimetric and linear energy transfer (LET) evaluation. Radiother Oncol 2020;149:197–204.32387488, BolsiA, PlacidiL, PicaA, Pencil beam scanning proton therapy for the treatment of craniopharyngioma complicated with radiation-induced cerebral vasculopathies: A dosimetric and linear energy transfer (LET) evaluation. Radiother Oncol 2020;149:197–204.32387488

  • (ChoY, ParkS, ByunHK, Impact of treatment-related lymphopenia on immunotherapy for advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2019;105:1065–1073.31476418)

    ChoY, ParkS, ByunHK,

    ChoY, ParkS, ByunHK, Impact of treatment-related lymphopenia on immunotherapy for advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2019;105:1065–1073.31476418, ChoY, ParkS, ByunHK, Impact of treatment-related lymphopenia on immunotherapy for advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2019;105:1065–1073.31476418

  • (VermaV, ShahC, MehtaMP. Clinical outcomes and toxicity of proton radiotherapy for breast cancer. Clin Breast Cancer 2016;16:145–154.26995159)

    VermaV, ShahC, MehtaMP. Clinical outcomes and toxicity of proton radiotherapy for breast cancer. Clin Breast Cancer

    VermaV, ShahC, MehtaMP. Clinical outcomes and toxicity of proton radiotherapy for breast cancer. Clin Breast Cancer 2016;16:145–154.26995159, VermaV, ShahC, MehtaMP. Clinical outcomes and toxicity of proton radiotherapy for breast cancer. Clin Breast Cancer 2016;16:145–154.26995159

  • J. Miszczyk, K. Rawojć, A. Panek, J. Swakoń, P. Prasanna, M. Rydygier (2015)

    Response of human lymphocytes to proton radiation of 60 MeV compared to 250 kV X-rays by the cytokinesis-block micronucleus assay.

    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 115 1

  • (BrodinNP, Munck af RosenscholdP, BlomstrandM, Hippocampal sparing radiotherapy for pediatric medulloblastoma: Impact of treatment margins and treatment technique. Neuro Oncol 2014;16: 594–602.24327585)

    BrodinNP, Munck af RosenscholdP, BlomstrandM,

    BrodinNP, Munck af RosenscholdP, BlomstrandM, Hippocampal sparing radiotherapy for pediatric medulloblastoma: Impact of treatment margins and treatment technique. Neuro Oncol 2014;16: 594–602.24327585, BrodinNP, Munck af RosenscholdP, BlomstrandM, Hippocampal sparing radiotherapy for pediatric medulloblastoma: Impact of treatment margins and treatment technique. Neuro Oncol 2014;16: 594–602.24327585

  • (Haas-KoganD, IndelicatoD, PaganettiH, National Cancer Institute workshop on proton therapy for children: Considerations regarding brainstem injury. Int J Radiat Oncol Biol Phys 2018;101: 152–168.29619963)

    Haas-KoganD, IndelicatoD, PaganettiH,

    Haas-KoganD, IndelicatoD, PaganettiH, National Cancer Institute workshop on proton therapy for children: Considerations regarding brainstem injury. Int J Radiat Oncol Biol Phys 2018;101: 152–168.29619963, Haas-KoganD, IndelicatoD, PaganettiH, National Cancer Institute workshop on proton therapy for children: Considerations regarding brainstem injury. Int J Radiat Oncol Biol Phys 2018;101: 152–168.29619963

  • Ohri (2012)

    6373

    Can J Urol, 19

  • Landry (2018)

    e1086

    Med Phys, 45

  • M. Xiang, D. Chang, E. Pollom (2020)

    Second cancer risk after primary cancer treatment with three‐dimensional conformal, intensity‐modulated, or proton beam radiation therapy

    Cancer, 126

  • Qutub (2016)

    NP1

    Technol Cancer Res Treat, 15

  • J. Leeman, P. Romesser, Ying Zhou, S. McBride, N. Riaz, E. Sherman, Marc Cohen, O. Cahlon, N. Lee (2017)

    Proton therapy for head and neck cancer: expanding the therapeutic window.

    The Lancet. Oncology, 18 5

  • (OhriN, DickerAP, ShowalterTN. Late toxicity rates following definitive radiotherapy for prostate cancer. Can J Urol 2012;19:6373–6380.22892261)

    OhriN, DickerAP, ShowalterTN. Late toxicity rates following definitive radiotherapy for prostate cancer. Can J Urol

    OhriN, DickerAP, ShowalterTN. Late toxicity rates following definitive radiotherapy for prostate cancer. Can J Urol 2012;19:6373–6380.22892261, OhriN, DickerAP, ShowalterTN. Late toxicity rates following definitive radiotherapy for prostate cancer. Can J Urol 2012;19:6373–6380.22892261

  • E. Basch, B. Reeve, S. Mitchell, S. Clauser, L. Minasian, A. Dueck, T. Mendoza, J. Hay, T. Atkinson, A. Abernethy, D. Bruner, C. Cleeland, J. Sloan, Ram Chilukuri, Paul Baumgartner, A. Denicoff, D. Germain, A. O'Mara, Alice Chen, J. Kelaghan, A. Bennett, L. Sit, L. Rogak, A. Barz, D. Paul, D. Schrag (2014)

    Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).

    Journal of the National Cancer Institute, 106 9

  • (NicholsRCJr., GeorgeTJ, ZaidenRAJr., Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicity. Acta Oncol 2013;52:498–505.23477361)

    NicholsRCJr., GeorgeTJ, ZaidenRAJr.,

    NicholsRCJr., GeorgeTJ, ZaidenRAJr., Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicity. Acta Oncol 2013;52:498–505.23477361, NicholsRCJr., GeorgeTJ, ZaidenRAJr., Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicity. Acta Oncol 2013;52:498–505.23477361

  • Jones (2017)

    777

    Ecancermedicalscience, 11

  • (QutubMA, KleinSB, BuchsbaumJC. Rapid RBE-weighted proton radiation dosimetry risk assessment. Technol Cancer Res Treat 2016; 15:NP1-NP7.)

    QutubMA, KleinSB, BuchsbaumJC. Rapid RBE-weighted proton radiation dosimetry risk assessment. Technol Cancer Res Treat

    QutubMA, KleinSB, BuchsbaumJC. Rapid RBE-weighted proton radiation dosimetry risk assessment. Technol Cancer Res Treat 2016; 15:NP1-NP7., QutubMA, KleinSB, BuchsbaumJC. Rapid RBE-weighted proton radiation dosimetry risk assessment. Technol Cancer Res Treat 2016; 15:NP1-NP7.

  • (DionisiF, AveryS, LukensJN, Proton therapy in adjuvant treatment of gastric cancer: Planning comparison with advanced x-ray therapy and feasibility report. Acta Oncol 2014;53:1312–1320.24797885)

    DionisiF, AveryS, LukensJN,

    DionisiF, AveryS, LukensJN, Proton therapy in adjuvant treatment of gastric cancer: Planning comparison with advanced x-ray therapy and feasibility report. Acta Oncol 2014;53:1312–1320.24797885, DionisiF, AveryS, LukensJN, Proton therapy in adjuvant treatment of gastric cancer: Planning comparison with advanced x-ray therapy and feasibility report. Acta Oncol 2014;53:1312–1320.24797885

  • Grassberger (2018)

    1222

    Int J Radiat Oncol Biol Phys, 101

  • P. Rossum, W. Deng, D. Routman, Amy Liu, Cai Xu, Y. Shiraishi, M. Peters, K. Merrell, C. Hallemeier, R. Mohan, Steven Lin (2020)

    Prediction of severe lymphopenia during chemoradiotherapy for esophageal cancer: development and validation of a pretreatment nomogram.

    Practical radiation oncology

  • (GeS, WangX, LiaoZ, Potential for improvements in robustness and optimality of intensity-modulated proton therapy for lung cancer with 4-dimensional robust optimization. Cancers (Basel) 2019;11.)

    GeS, WangX, LiaoZ,

    GeS, WangX, LiaoZ, Potential for improvements in robustness and optimality of intensity-modulated proton therapy for lung cancer with 4-dimensional robust optimization. Cancers (Basel) 2019;11., GeS, WangX, LiaoZ, Potential for improvements in robustness and optimality of intensity-modulated proton therapy for lung cancer with 4-dimensional robust optimization. Cancers (Basel) 2019;11.

  • McDonald (2016)

    32

    Radiat Oncol, 11

  • (StraubJM, NewJ, HamiltonCD, Radiation-induced fibrosis: Mechanisms and implications for therapy. J Cancer Res Clin Oncol 2015;141:1985–1994.25910988)

    StraubJM, NewJ, HamiltonCD,

    StraubJM, NewJ, HamiltonCD, Radiation-induced fibrosis: Mechanisms and implications for therapy. J Cancer Res Clin Oncol 2015;141:1985–1994.25910988, StraubJM, NewJ, HamiltonCD, Radiation-induced fibrosis: Mechanisms and implications for therapy. J Cancer Res Clin Oncol 2015;141:1985–1994.25910988

  • Chuong (2016)

    488

    Int J Radiat Oncol Biol Phys, 95

  • Sio (2016)

    1107

    Int J Radiat Oncol Biol Phys, 95

  • Mishra (2017)

    228

    Int J Radiat Oncol Biol Phys, 97

  • (NicholsRC, HuhS, LiZ, Proton therapy for pancreatic cancer. World J Gastrointest Oncol 2015;7:141–147.26380057)

    NicholsRC, HuhS, LiZ,

    NicholsRC, HuhS, LiZ, Proton therapy for pancreatic cancer. World J Gastrointest Oncol 2015;7:141–147.26380057, NicholsRC, HuhS, LiZ, Proton therapy for pancreatic cancer. World J Gastrointest Oncol 2015;7:141–147.26380057

  • Wei Liu, Xiaodong Zhang, Yupeng Li, R. Mohan (2012)

    Robust optimization of intensity modulated proton therapy.

    Medical physics, 39 2

  • Sancar (2004)

    39

    Annu Rev Biochem, 73

  • (NewmanAM, LovejoyAF, KlassDM, Integrated digital error suppression for improved detection of circulating tumor DNA. Nat Biotechnol 2016;34:547–555.27018799)

    NewmanAM, LovejoyAF, KlassDM,

    NewmanAM, LovejoyAF, KlassDM, Integrated digital error suppression for improved detection of circulating tumor DNA. Nat Biotechnol 2016;34:547–555.27018799, NewmanAM, LovejoyAF, KlassDM, Integrated digital error suppression for improved detection of circulating tumor DNA. Nat Biotechnol 2016;34:547–555.27018799

  • S. Horn, N. Fournier-Bidoz, V. Pernin, D. Peurien, M. Vaillant, R. Dendale, A. Fourquet, Y. Kirova (2016)

    Comparison of passive-beam proton therapy, helical tomotherapy and 3D conformal radiation therapy in Hodgkin's lymphoma female patients receiving involved-field or involved site radiation therapy.

    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 20 2

  • D. Indelicato, S. Flampouri, R. Rotondo, J. Bradley, C. Morris, P. Aldana, E. Sandler, N. Mendenhall (2014)

    Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy

    Acta Oncologica, 53

  • Romesser (2016)

    286

    Radiother Oncol, 118

  • (FallsKC, SharmaRA, LawrenceYR, Radiation-drug combinations to improve clinical outcomes and reduce normal tissue toxicities: Current challenges and new approaches: Report of the symposium held at the 63rd Annual meeting of the Radiation Research Society, 15–18 October 2017; Cancun, Mexico. Radiat Res 2018;190:350–360.30280985)

    FallsKC, SharmaRA, LawrenceYR,

    FallsKC, SharmaRA, LawrenceYR, Radiation-drug combinations to improve clinical outcomes and reduce normal tissue toxicities: Current challenges and new approaches: Report of the symposium held at the 63rd Annual meeting of the Radiation Research Society, 15–18 October 2017; Cancun, Mexico. Radiat Res 2018;190:350–360.30280985, FallsKC, SharmaRA, LawrenceYR, Radiation-drug combinations to improve clinical outcomes and reduce normal tissue toxicities: Current challenges and new approaches: Report of the symposium held at the 63rd Annual meeting of the Radiation Research Society, 15–18 October 2017; Cancun, Mexico. Radiat Res 2018;190:350–360.30280985

  • (LambinP, LieverseRIY, EckertF, Lymphocyte-sparing radiotherapy: The rationale for protecting lymphocyte-rich organs when combining radiotherapy with immunotherapy. Semin Radiat Oncol 2020;30:187–193.32381298)

    LambinP, LieverseRIY, EckertF,

    LambinP, LieverseRIY, EckertF, Lymphocyte-sparing radiotherapy: The rationale for protecting lymphocyte-rich organs when combining radiotherapy with immunotherapy. Semin Radiat Oncol 2020;30:187–193.32381298, LambinP, LieverseRIY, EckertF, Lymphocyte-sparing radiotherapy: The rationale for protecting lymphocyte-rich organs when combining radiotherapy with immunotherapy. Semin Radiat Oncol 2020;30:187–193.32381298

  • Bahn (2020)

    571

    Int J Radiat Oncol Biol Phys, 107

  • Mori (2018)

    e994

    Med Phys, 45

  • (TerashimaK, DemizuY, HashimotoN, A phase I/II study of gemcitabine-concurrent proton radiotherapy for locally advanced pancreatic cancer without distant metastasis. Radiother Oncol 2012; 103:25–31.22300608)

    TerashimaK, DemizuY, HashimotoN,

    TerashimaK, DemizuY, HashimotoN, A phase I/II study of gemcitabine-concurrent proton radiotherapy for locally advanced pancreatic cancer without distant metastasis. Radiother Oncol 2012; 103:25–31.22300608, TerashimaK, DemizuY, HashimotoN, A phase I/II study of gemcitabine-concurrent proton radiotherapy for locally advanced pancreatic cancer without distant metastasis. Radiother Oncol 2012; 103:25–31.22300608

  • (NikjooH, UeharaS, EmfietzoglouD, A database of frequency distributions of energy depositions in small-size targets by electrons and ions. Radiat Prot Dosimetry 2011;143:145–151.21109546)

    NikjooH, UeharaS, EmfietzoglouD,

    NikjooH, UeharaS, EmfietzoglouD, A database of frequency distributions of energy depositions in small-size targets by electrons and ions. Radiat Prot Dosimetry 2011;143:145–151.21109546, NikjooH, UeharaS, EmfietzoglouD, A database of frequency distributions of energy depositions in small-size targets by electrons and ions. Radiat Prot Dosimetry 2011;143:145–151.21109546

  • Paganetti (2018)

    2

    Int J Part Ther, 5

  • N. Taunk, B. Haffty, J. Kostis, S. Goyal (2015)

    Radiation-Induced Heart Disease: Pathologic Abnormalities and Putative Mechanisms

    Frontiers in Oncology, 5

  • L. Stick, Jen Yu, M. Maraldo, M. Aznar, A. Pedersen, S. Bentzen, I. Vogelius (2017)

    Joint Estimation of Cardiac Toxicity and Recurrence Risks After Comprehensive Nodal Photon Versus Proton Therapy for Breast Cancer.

    International journal of radiation oncology, biology, physics, 97 4

  • McClelland (2019)

    8

    Clin Neurol Neurosurg, 176

  • Chang (2017)

    41

    Int J Radiat Oncol Biol Phys, 99

  • F. Tommasino, M. Durante, V. D’Avino, R. Liuzzi, M. Conson, P. Farace, G. Palma, M. Schwarz, L. Cella, R. Pacelli (2017)

    Model-based approach for quantitative estimates of skin, heart, and lung toxicity risk for left-side photon and proton irradiation after breast-conserving surgery

    Acta Oncologica, 56

  • Liu (2012)

    1079

    Med Phys, 39

  • (PrasannaPG, StoneHB, WongRS, Normal tissue protection for improving radiotherapy: Where are the gaps? Transl Cancer Res 2012;1:35–48.22866245)

    PrasannaPG, StoneHB, WongRS,

    PrasannaPG, StoneHB, WongRS, Normal tissue protection for improving radiotherapy: Where are the gaps? Transl Cancer Res 2012;1:35–48.22866245, PrasannaPG, StoneHB, WongRS, Normal tissue protection for improving radiotherapy: Where are the gaps? Transl Cancer Res 2012;1:35–48.22866245

  • (MirschJ, TommasinoF, FrohnsA, Direct measurement of the 3-dimensional DNA lesion distribution induced by energetic charged particles in a mouse model tissue. Proc Natl Acad Sci U S A 2015; 112:12396–12401.26392532)

    MirschJ, TommasinoF, FrohnsA,

    MirschJ, TommasinoF, FrohnsA, Direct measurement of the 3-dimensional DNA lesion distribution induced by energetic charged particles in a mouse model tissue. Proc Natl Acad Sci U S A 2015; 112:12396–12401.26392532, MirschJ, TommasinoF, FrohnsA, Direct measurement of the 3-dimensional DNA lesion distribution induced by energetic charged particles in a mouse model tissue. Proc Natl Acad Sci U S A 2015; 112:12396–12401.26392532

  • Bolsi (2020)

    197

    Radiother Oncol, 149

  • N. Brodin, P. Rosenschöld, M. Blomstrand, Anne Kiil-Berthlesen, C. Hollensen, I. Vogelius, B. Lannering, S. Bentzen, T. Björk-Eriksson (2014)

    Hippocampal sparing radiotherapy for pediatric medulloblastoma: impact of treatment margins and treatment technique.

    Neuro-oncology, 16 4

  • Pan (2010)

    S94

    Int J Radiat Oncol Biol Phys, 76

  • (HongTS, RyanDP, BorgerDR, A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinoma. Int J Radiat Oncol Biol Phys 2014;89:830–838.24867540)

    HongTS, RyanDP, BorgerDR,

    HongTS, RyanDP, BorgerDR, A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinoma. Int J Radiat Oncol Biol Phys 2014;89:830–838.24867540, HongTS, RyanDP, BorgerDR, A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinoma. Int J Radiat Oncol Biol Phys 2014;89:830–838.24867540

  • J. Ödén, K. Eriksson, I. Toma-Dasu (2017)

    Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy

    Medical Physics, 44

  • Ricky Sharma, R. Plummer, J. Stock, T. Greenhalgh, O. Ataman, S. Kelly, R. Clay, R. Adams, R. Baird, L. Billingham, Sarah Brown, Sean Buckland, H. Bulbeck, A. Chalmers, G. Clack, A. Cranston, L. Damstrup, R. Ferraldeschi, M. Forster, J. Golec, R. Hagan, E. Hall, A. Hanauske, K. Harrington, T. Haswell, M. Hawkins, T. Illidge, Hazel Jones, A. Kennedy, F. McDonald, T. Melcher, J. O’Connor, Jack Pollard, M. Saunders, D. Sebag‐Montefiore, M. Smitt, J. Staffurth, I. Stratford, S. Wedge (2016)

    Clinical development of new drug–radiotherapy combinations

    Nature Reviews Clinical Oncology, 13

  • Taunk (2015)

    39

    Front Oncol, 5

  • Cho (2019)

    1065

    Int J Radiat Oncol Biol Phys, 105

  • Nikjoo (2011)

    145

    Radiat Prot Dosimetry, 143

  • Yock (2019)

    200

    Pract Radiat Oncol, 9

  • Routman (2019)

    63

    Adv Radiat Oncol, 4

  • A. Dasu, A. Flejmer, A. Edvardsson, P. Nyström (2018)

    Normal tissue sparing potential of scanned proton beams with and without respiratory gating for the treatment of internal mammary nodes in breast cancer radiotherapy.

    Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics, 52

  • (LeemanJE, RomesserPB, ZhouY, Proton therapy for head and neck cancer: Expanding the therapeutic window. Lancet Oncol 2017; 18:e254–e265.28456587)

    LeemanJE, RomesserPB, ZhouY,

    LeemanJE, RomesserPB, ZhouY, Proton therapy for head and neck cancer: Expanding the therapeutic window. Lancet Oncol 2017; 18:e254–e265.28456587, LeemanJE, RomesserPB, ZhouY, Proton therapy for head and neck cancer: Expanding the therapeutic window. Lancet Oncol 2017; 18:e254–e265.28456587

  • S. Palayoor, M. John-Aryankalayil, A. Makinde, M. Falduto, S. Magnuson, C. Coleman (2014)

    Differential Expression of Stress and Immune Response Pathway Transcripts and miRNAs in Normal Human Endothelial Cells Subjected to Fractionated or Single-Dose Radiation

    Molecular Cancer Research, 12

  • C. Nantavithya, D. Gomez, Xiong Wei, R. Komaki, Z. Liao, Steven Lin, M. Jeter, Q. Nguyen, Heng Li, Xiaodong Zhang, F. Poenisch, X. Zhu, P. Balter, Lei Feng, N. Choi, R. Mohan, Joe Chang (2018)

    Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer.

    International journal of radiation oncology, biology, physics, 101 3

  • (HutchinsBI, BakerKL, DavisMT, The NIH open citation collection: A public access, broad coverage resource. PLoS Biol 2019;17:e3000385.)

    HutchinsBI, BakerKL, DavisMT,

    HutchinsBI, BakerKL, DavisMT, The NIH open citation collection: A public access, broad coverage resource. PLoS Biol 2019;17:e3000385., HutchinsBI, BakerKL, DavisMT, The NIH open citation collection: A public access, broad coverage resource. PLoS Biol 2019;17:e3000385.

  • (WillersH, AllenA, GrosshansD, Toward a variable RBE for proton beam therapy. Radiother Oncol 2018;128:68–75.29910006)

    WillersH, AllenA, GrosshansD,

    WillersH, AllenA, GrosshansD, Toward a variable RBE for proton beam therapy. Radiother Oncol 2018;128:68–75.29910006, WillersH, AllenA, GrosshansD, Toward a variable RBE for proton beam therapy. Radiother Oncol 2018;128:68–75.29910006

  • S. James, C. Grassberger, Hsiao-Ming Lu (2018)

    Considerations when treating lung cancer with passive scatter or active scanning proton therapy.

    Translational lung cancer research, 7 2

  • (PaganettiH. Proton relative biological effectiveness - Uncertainties and opportunities. Int J Part Ther 2018;5:2–14.30370315)

    PaganettiH. Proton relative biological effectiveness - Uncertainties and opportunities. Int J Part Ther

    PaganettiH. Proton relative biological effectiveness - Uncertainties and opportunities. Int J Part Ther 2018;5:2–14.30370315, PaganettiH. Proton relative biological effectiveness - Uncertainties and opportunities. Int J Part Ther 2018;5:2–14.30370315

  • (SharmaRA, PlummerR, StockJK, Clinical development of new drug-radiotherapy combinations. Nat Rev Clin Oncol 2016;13: 627–642.27245279)

    SharmaRA, PlummerR, StockJK,

    SharmaRA, PlummerR, StockJK, Clinical development of new drug-radiotherapy combinations. Nat Rev Clin Oncol 2016;13: 627–642.27245279, SharmaRA, PlummerR, StockJK, Clinical development of new drug-radiotherapy combinations. Nat Rev Clin Oncol 2016;13: 627–642.27245279

  • (MishraMV, AggarwalS, BentzenSM, Establishing evidence-based indications for proton therapy: An overview of current clinical trials. Int J Radiat Oncol Biol Phys 2017;97:228–235.28068231)

    MishraMV, AggarwalS, BentzenSM,

    MishraMV, AggarwalS, BentzenSM, Establishing evidence-based indications for proton therapy: An overview of current clinical trials. Int J Radiat Oncol Biol Phys 2017;97:228–235.28068231, MishraMV, AggarwalS, BentzenSM, Establishing evidence-based indications for proton therapy: An overview of current clinical trials. Int J Radiat Oncol Biol Phys 2017;97:228–235.28068231

  • Darby (2013)

    987

    N Engl J Med, 368

  • (MoriS, KnopfAC, UmegakiK. Motion management in particle therapy. Med Phys 2018;45:e994–e1010.30421815)

    MoriS, KnopfAC, UmegakiK. Motion management in particle therapy. Med Phys

    MoriS, KnopfAC, UmegakiK. Motion management in particle therapy. Med Phys 2018;45:e994–e1010.30421815, MoriS, KnopfAC, UmegakiK. Motion management in particle therapy. Med Phys 2018;45:e994–e1010.30421815

  • S. Kralik, T. Mereniuk, L. Grignon, C. Shih, C. Ho, W. Finke, P. Coleman, G. Watson, J. Buchsbaum (2018)

    Radiation-Induced Cerebral Microbleeds in Pediatric Patients With Brain Tumors Treated With Proton Radiation Therapy.

    International journal of radiation oncology, biology, physics, 102 5

  • Newman (2016)

    547

    Nat Biotechnol, 34

  • Terence Sio, H. Lin, Q. Shi, G. Gunn, C. Cleeland, J. Lee, Mike Hernandez, P. Blanchard, N. Thaker, J. Phan, D. Rosenthal, A. Garden, W. Morrison, C. Fuller, T. Mendoza, R. Mohan, X. Wang, S. Frank (2016)

    Intensity-Modulated Proton Therapy ( IMPT ) versus Intensity-Modulated Photon Radiotherapy ( IMRT ) for Oropharyngeal Cancer : First Comparative Results of Patient-Reported Outcomes

  • (BaumannM, KrauseM, OvergaardJ, Radiation oncology in the era of precision medicine. Nature Reviews Cancer 2016;16: 234–249.27009394)

    BaumannM, KrauseM, OvergaardJ,

    BaumannM, KrauseM, OvergaardJ, Radiation oncology in the era of precision medicine. Nature Reviews Cancer 2016;16: 234–249.27009394, BaumannM, KrauseM, OvergaardJ, Radiation oncology in the era of precision medicine. Nature Reviews Cancer 2016;16: 234–249.27009394

  • (JadonR, PembrokeCA, HannaCL, A systematic review of organ motion and image-guided strategies in external beam radiotherapy for cervical cancer. Clin Oncol (R Coll Radiol) 2014;26:185–196.24566332)

    JadonR, PembrokeCA, HannaCL,

    JadonR, PembrokeCA, HannaCL, A systematic review of organ motion and image-guided strategies in external beam radiotherapy for cervical cancer. Clin Oncol (R Coll Radiol) 2014;26:185–196.24566332, JadonR, PembrokeCA, HannaCL, A systematic review of organ motion and image-guided strategies in external beam radiotherapy for cervical cancer. Clin Oncol (R Coll Radiol) 2014;26:185–196.24566332

  • (PalayoorST, John-AryankalayilM, MakindeAY, Differential expression of stress and immune response pathway transcripts and mirnas in normal human endothelial cells subjected to fractionated or single-dose radiation. Mol Cancer Res 2014;12: 1002–1015.24784841)

    PalayoorST, John-AryankalayilM, MakindeAY,

    PalayoorST, John-AryankalayilM, MakindeAY, Differential expression of stress and immune response pathway transcripts and mirnas in normal human endothelial cells subjected to fractionated or single-dose radiation. Mol Cancer Res 2014;12: 1002–1015.24784841, PalayoorST, John-AryankalayilM, MakindeAY, Differential expression of stress and immune response pathway transcripts and mirnas in normal human endothelial cells subjected to fractionated or single-dose radiation. Mol Cancer Res 2014;12: 1002–1015.24784841

  • Hall (2018)

    854

    Int J Radiat Oncol Biol Phys, 101

  • (NtentasG, DedeckovaK, AndrlikM, Clinical intensity modulated proton therapy for Hodgkin lymphoma: Which patients benefit the most? Pract Radiat Oncol 2019;9:179–187.30708133)

    NtentasG, DedeckovaK, AndrlikM,

    NtentasG, DedeckovaK, AndrlikM, Clinical intensity modulated proton therapy for Hodgkin lymphoma: Which patients benefit the most? Pract Radiat Oncol 2019;9:179–187.30708133, NtentasG, DedeckovaK, AndrlikM, Clinical intensity modulated proton therapy for Hodgkin lymphoma: Which patients benefit the most? Pract Radiat Oncol 2019;9:179–187.30708133

  • Koh (2014)

    7361

    Proc Natl Acad Sci U S A, 111

  • (GeorgakilasAG, O’NeillP, StewartRD. Induction and repair of clustered DNA lesions: What do we know so far? Radiat Res 2013; 180:100–109.23682596)

    GeorgakilasAG, O?NeillP, StewartRD. Induction and repair of clustered DNA lesions: What do we know so far?

    GeorgakilasAG, O’NeillP, StewartRD. Induction and repair of clustered DNA lesions: What do we know so far? Radiat Res 2013; 180:100–109.23682596, GeorgakilasAG, O’NeillP, StewartRD. Induction and repair of clustered DNA lesions: What do we know so far? Radiat Res 2013; 180:100–109.23682596

  • (BaschE, ReeveBB, MitchellSA, Development of the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst 2014;106.)

    BaschE, ReeveBB, MitchellSA,

    BaschE, ReeveBB, MitchellSA, Development of the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst 2014;106., BaschE, ReeveBB, MitchellSA, Development of the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst 2014;106.

  • Dionisi (2014)

    1312

    Acta Oncol, 53

  • Kralik (2018)

    1465

    Int J Radiat Oncol Biol Phys, 102

  • Reid Thompson, S. Mayekar, H. Zhai, S. Both, S. Apisarnthanarax, J. Metz, J. Plastaras, E. Ben-Josef (2014)

    A dosimetric comparison of proton and photon therapy in unresectable cancers of the head of pancreas.

    Medical physics, 41 8

  • R. Nichols, T. George, R. Zaiden, Z. Awad, H. Asbun, S. Huh, M. Ho, N. Mendenhall, C. Morris, B. Hoppe (2013)

    Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicity

    Acta Oncologica, 52

  • Coleman (2018)

    250

    Int J Radiat Oncol Biol Phys, 101

  • Liu (2013)

    Effectiveness of robust optimization in intensity-modulated proton therapy planning for head and neck cancers

    Med Phys, 40

  • C. Coleman, P. Prasanna, E. Bernhard, J. Buchsbaum, Mansoor Ahmed, J. Capala, C. Obcemea, J. Deye, David Pistenmma, B. Vikram, J. Bernier, M. Dosanjh (2018)

    Accurate, Precision Radiation Medicine: A Meta-Strategy for Impacting Cancer Care, Global Health, and Nuclear Policy and Mitigating Radiation Injury From Necessary Medical Use, Space Exploration, and Potential Terrorism.

    International journal of radiation oncology, biology, physics, 101 2

  • Fang (2015)

    1118

    Cancer, 121

  • Aaron Newman, A. Lovejoy, D. Klass, D. Kurtz, J. Chabon, F. Scherer, H. Stehr, C. Liu, S. Bratman, C. Say, Li Zhou, J. Carter, R. West, G. Sledge, J. Shrager, B. Loo, J. Neal, H. Wakelee, M. Diehn, Ash Alizadeh (2016)

    Integrated digital error suppression for improved detection of circulating tumor DNA

    Nature biotechnology, 34

  • Liamsuwan (2011)

    141

    Int J Radiat Biol, 87

  • Pugh (2014)

    1451

    J Immunol, 193

  • (LiaoZ, LeeJJ, KomakiR, Bayesian adaptive randomization trial of passive scattering proton therapy and intensity-modulated photon radiotherapy for locally advanced non-small-cell lung cancer. J Clin Oncol 2018;36:1813–1822.29293386)

    LiaoZ, LeeJJ, KomakiR,

    LiaoZ, LeeJJ, KomakiR, Bayesian adaptive randomization trial of passive scattering proton therapy and intensity-modulated photon radiotherapy for locally advanced non-small-cell lung cancer. J Clin Oncol 2018;36:1813–1822.29293386, LiaoZ, LeeJJ, KomakiR, Bayesian adaptive randomization trial of passive scattering proton therapy and intensity-modulated photon radiotherapy for locally advanced non-small-cell lung cancer. J Clin Oncol 2018;36:1813–1822.29293386

  • (LiuW, SchildSE, ChangJY, Exploratory study of 4D versus 3D robust optimization in intensity modulated proton therapy for lung cancer. Int J Radiat Oncol Biol Phys 2016;95:523–533.26725727)

    LiuW, SchildSE, ChangJY,

    LiuW, SchildSE, ChangJY, Exploratory study of 4D versus 3D robust optimization in intensity modulated proton therapy for lung cancer. Int J Radiat Oncol Biol Phys 2016;95:523–533.26725727, LiuW, SchildSE, ChangJY, Exploratory study of 4D versus 3D robust optimization in intensity modulated proton therapy for lung cancer. Int J Radiat Oncol Biol Phys 2016;95:523–533.26725727

  • (KohW, PanW, GawadC, Noninvasive in vivo monitoring of tissue-specific global gene expression in humans. Proc Natl Acad Sci U S A 2014;111:7361–7366.24799715)

    KohW, PanW, GawadC,

    KohW, PanW, GawadC, Noninvasive in vivo monitoring of tissue-specific global gene expression in humans. Proc Natl Acad Sci U S A 2014;111:7361–7366.24799715, KohW, PanW, GawadC, Noninvasive in vivo monitoring of tissue-specific global gene expression in humans. Proc Natl Acad Sci U S A 2014;111:7361–7366.24799715

  • R. Nichols, S. Huh, Zuofeng Li, M. Rutenberg (2015)

    Proton therapy for pancreatic cancer.

    World journal of gastrointestinal oncology, 7 9

  • C. Grassberger, T. Hong, T. Hato, B. Yeap, J. Wo, M. Tracy, T. Bortfeld, J. Wolfgang, C. Eyler, L. Goyal, Jeffrey Clark, C. Crane, E. Koay, M. Cobbold, T. Delaney, R. Jain, A. Zhu, D. Duda (2018)

    Differential Association Between Circulating Lymphocyte Populations With Outcome After Radiation Therapy in Subtypes of Liver Cancer.

    International journal of radiation oncology, biology, physics, 101 5

  • Wei Liu, S. Schild, Joe Chang, Z. Liao, Yu-Hui Chang, Z. Wen, Jiajian Shen, J. Stoker, Xiaoning Ding, Yanle Hu, N. Sahoo, M. Herman, C. Vargas, S. Keole, W. Wong, M. Bues (2016)

    Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer.

    International journal of radiation oncology, biology, physics, 95 1

  • S. Kralik, C. Ho, W. Finke, J. Buchsbaum, C. Haskins, C. Shih (2015)

    Radiation Necrosis in Pediatric Patients with Brain Tumors Treated with Proton Radiotherapy

    American Journal of Neuroradiology, 36

  • P. Prasanna, D. Narayanan, Kehui Zhang, A. Rahbar, C. Coleman, B. Vikram (2020)

    Radiation Biomarkers: Can Small Businesses Drive Accurate Radiation Precision Medicine?

    Radiation Research, 193

  • (DuranteM, BrennerDJ, FormentiSC. Does heavy ion therapy work through the immune system? Int J Radiat Oncol Biol Phys 2016;96: 934–936.27869095)

    DuranteM, BrennerDJ, FormentiSC. Does heavy ion therapy work through the immune system?

    DuranteM, BrennerDJ, FormentiSC. Does heavy ion therapy work through the immune system? Int J Radiat Oncol Biol Phys 2016;96: 934–936.27869095, DuranteM, BrennerDJ, FormentiSC. Does heavy ion therapy work through the immune system? Int J Radiat Oncol Biol Phys 2016;96: 934–936.27869095

  • St James (2018)

    210

    Transl Lung Cancer Res, 7

  • Falls (2018)

    350

    Radiat Res, 190

  • Weber (2015)

    389

    J Neurooncol, 121

  • (PanCC, KavanaghBD, DawsonLA, Radiation-associated liver injury. Int J Radiat Oncol Biol Phys 2010;76:S94–S100.20171524)

    PanCC, KavanaghBD, DawsonLA,

    PanCC, KavanaghBD, DawsonLA, Radiation-associated liver injury. Int J Radiat Oncol Biol Phys 2010;76:S94–S100.20171524, PanCC, KavanaghBD, DawsonLA, Radiation-associated liver injury. Int J Radiat Oncol Biol Phys 2010;76:S94–S100.20171524

  • Kelly Falls, Ricky Sharma, Y. Lawrence, R. Amos, S. Advani, Mansoor Ahmed, B. Vikram, C. Coleman, P. Prasanna (2018)

    Radiation-Drug Combinations to Improve Clinical Outcomes and Reduce Normal Tissue Toxicities: Current Challenges and New Approaches: Report of the Symposium Held at the 63rd Annual Meeting of the Radiation Research Society, 15–18 October 2017; Cancun, Mexico

    Radiation Research, 190

  • (van RossumPSN, DengW, RoutmanDM, Prediction of severe lymphopenia during chemoradiation therapy for esophageal cancer: Development and validation of a pretreatment nomogram. Pract Radiat Oncol 2020;10:e16–e26.31369887)

    van RossumPSN, DengW, RoutmanDM,

    van RossumPSN, DengW, RoutmanDM, Prediction of severe lymphopenia during chemoradiation therapy for esophageal cancer: Development and validation of a pretreatment nomogram. Pract Radiat Oncol 2020;10:e16–e26.31369887, van RossumPSN, DengW, RoutmanDM, Prediction of severe lymphopenia during chemoradiation therapy for esophageal cancer: Development and validation of a pretreatment nomogram. Pract Radiat Oncol 2020;10:e16–e26.31369887

  • (MendenhallNP, HoppeBS, NicholsRC, Five-year outcomes from 3 prospective trials of image-guided proton therapy for prostate cancer. Int J Radiat Oncol Biol Phys 2014;88:596–602.24521677)

    MendenhallNP, HoppeBS, NicholsRC,

    MendenhallNP, HoppeBS, NicholsRC, Five-year outcomes from 3 prospective trials of image-guided proton therapy for prostate cancer. Int J Radiat Oncol Biol Phys 2014;88:596–602.24521677, MendenhallNP, HoppeBS, NicholsRC, Five-year outcomes from 3 prospective trials of image-guided proton therapy for prostate cancer. Int J Radiat Oncol Biol Phys 2014;88:596–602.24521677

  • (ColemanCN, PrasannaPGS, BernhardEJ, Accurate, precision radiation medicine: A meta-strategy for impacting cancer care, global health, and nuclear policy and mitigating radiation injury from necessary medical use, space exploration, and potential terrorism. Int J Radiat Oncol Biol Phys 2018;101:250–253.29726348)

    ColemanCN, PrasannaPGS, BernhardEJ,

    ColemanCN, PrasannaPGS, BernhardEJ, Accurate, precision radiation medicine: A meta-strategy for impacting cancer care, global health, and nuclear policy and mitigating radiation injury from necessary medical use, space exploration, and potential terrorism. Int J Radiat Oncol Biol Phys 2018;101:250–253.29726348, ColemanCN, PrasannaPGS, BernhardEJ, Accurate, precision radiation medicine: A meta-strategy for impacting cancer care, global health, and nuclear policy and mitigating radiation injury from necessary medical use, space exploration, and potential terrorism. Int J Radiat Oncol Biol Phys 2018;101:250–253.29726348

  • F. Dionisi, S. Avery, J. Lukens, Xuanfeng Ding, J. Kralik, M. Kirk, R. Roses, M. Amichetti, J. Metz, J. Plastaras (2014)

    Proton therapy in adjuvant treatment of gastric cancer: Planning comparison with advanced x-ray therapy and feasibility report

    Acta Oncologica, 53

  • Willers (2018)

    68

    Radiother Oncol, 128

  • Liao (2018)

    1813

    J Clin Oncol, 36

  • Terashima (2012)

    25

    Radiother Oncol, 103

  • D. Haas-Kogan, D. Indelicato, H. Paganetti, N. Esiashvili, A. Mahajan, T. Yock, S. Flampouri, S. MacDonald, M. Fouladi, Kry Stephen, J. Kalapurakal, S. Terezakis, H. Kooy, D. Grosshans, M. Makrigiorgos, K. Mishra, T. Poussaint, K. Cohen, T. Fitzgerald, V. Gondi, Arthur Liu, J. Michalski, D. Mirkovic, R. Mohan, S. Perkins, K. Wong, B. Vikram, J. Buchsbaum, L. Kun (2018)

    National Cancer Institute Workshop on Proton Therapy for Children: Considerations Regarding Brainstem Injury.

    International journal of radiation oncology, biology, physics, 101 1

  • (OdenJ, ErikssonK, Toma-DasuI. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy. Med Phys 2017;44:810–822.28107554)

    OdenJ, ErikssonK, Toma-DasuI. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy. Med Phys

    OdenJ, ErikssonK, Toma-DasuI. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy. Med Phys 2017;44:810–822.28107554, OdenJ, ErikssonK, Toma-DasuI. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy. Med Phys 2017;44:810–822.28107554

  • (PughJL, SukhinaAS, SeedTM, Histone deacetylation critically determines T cell subset radiosensitivity. J Immunol 2014;193: 1451–1458.24990082)

    PughJL, SukhinaAS, SeedTM,

    PughJL, SukhinaAS, SeedTM, Histone deacetylation critically determines T cell subset radiosensitivity. J Immunol 2014;193: 1451–1458.24990082, PughJL, SukhinaAS, SeedTM, Histone deacetylation critically determines T cell subset radiosensitivity. J Immunol 2014;193: 1451–1458.24990082

  • Gjyshi (2021)

    269

    J Thorac Oncol, 16

  • Verma (2016)

    145

    Clin Breast Cancer, 16

  • Knopf (2011)

    7257

    Phys Med Biol, 56

  • (BekelmanJE, LuH, PughS, Pragmatic randomised clinical trial of proton versus photon therapy for patients with non-metastatic breast cancer: The radiotherapy comparative effectiveness (Rad-Comp) consortium trial protocol. BMJ Open 2019;9:e025556.)

    BekelmanJE, LuH, PughS,

    BekelmanJE, LuH, PughS, Pragmatic randomised clinical trial of proton versus photon therapy for patients with non-metastatic breast cancer: The radiotherapy comparative effectiveness (Rad-Comp) consortium trial protocol. BMJ Open 2019;9:e025556., BekelmanJE, LuH, PughS, Pragmatic randomised clinical trial of proton versus photon therapy for patients with non-metastatic breast cancer: The radiotherapy comparative effectiveness (Rad-Comp) consortium trial protocol. BMJ Open 2019;9:e025556.

  • Shuryak (2017)

    476

    Radiat Res, 187

  • (PrasannaPGS, NarayananD, ZhangK, Radiation biomarkers: Can small businesses drive accurate radiation precision medicine? Radiat Res 2020;193:199–208.31910120)

    PrasannaPGS, NarayananD, ZhangK,

    PrasannaPGS, NarayananD, ZhangK, Radiation biomarkers: Can small businesses drive accurate radiation precision medicine? Radiat Res 2020;193:199–208.31910120, PrasannaPGS, NarayananD, ZhangK, Radiation biomarkers: Can small businesses drive accurate radiation precision medicine? Radiat Res 2020;193:199–208.31910120

  • Miszczyk (2018)

    23

    Clin Transl Radiat Oncol, 9

  • (DarbySC, EwertzM, McGaleP, Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013; 368:987–998.23484825)

    DarbySC, EwertzM, McGaleP,

    DarbySC, EwertzM, McGaleP, Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013; 368:987–998.23484825, DarbySC, EwertzM, McGaleP, Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013; 368:987–998.23484825

  • (GerelchuluunA, HongZ, SunL, Induction of in situ DNA double-strand breaks and apoptosis by 200 MeV protons and 10 MV x-rays in human tumour cell lines. Int J Radiat Biol 2011;87: 57–70.20954835)

    GerelchuluunA, HongZ, SunL,

    GerelchuluunA, HongZ, SunL, Induction of in situ DNA double-strand breaks and apoptosis by 200 MeV protons and 10 MV x-rays in human tumour cell lines. Int J Radiat Biol 2011;87: 57–70.20954835, GerelchuluunA, HongZ, SunL, Induction of in situ DNA double-strand breaks and apoptosis by 200 MeV protons and 10 MV x-rays in human tumour cell lines. Int J Radiat Biol 2011;87: 57–70.20954835

  • (SchippersJM, LomaxAJ. Emerging technologies in proton therapy. Acta Oncol 2011;50:838–850.21767183)

    SchippersJM, LomaxAJ. Emerging technologies in proton therapy. Acta Oncol

    SchippersJM, LomaxAJ. Emerging technologies in proton therapy. Acta Oncol 2011;50:838–850.21767183, SchippersJM, LomaxAJ. Emerging technologies in proton therapy. Acta Oncol 2011;50:838–850.21767183

  • Gondi (2016)

    334

    Nat Rev Neurol, 12

  • Jakobi (2015)

    1658

    Acta Oncol, 54

  • D. Weber, C. Ares, R. Malyapa, F. Albertini, G. Calaminus, U. Kliebsch, L. Mikroutsikos, Petra Morach, A. Bolsi, T. Lomax, R. Schneider (2014)

    Tumor control and QoL outcomes of very young children with atypical teratoid/rhabdoid Tumor treated with focal only chemo-radiation therapy using pencil beam scanning proton therapy

    Journal of Neuro-Oncology, 121

  • Prasanna (2020)

    199

    Radiat Res, 193

  • (WeberDC, AresC, MalyapaR, Tumor control and qol outcomes of very young children with atypical teratoid/rhabdoid tumor treated with focal only chemo-radiation therapy using pencil beam scanning proton therapy. J Neurooncol 2015;121:389–397.25362544)

    WeberDC, AresC, MalyapaR,

    WeberDC, AresC, MalyapaR, Tumor control and qol outcomes of very young children with atypical teratoid/rhabdoid tumor treated with focal only chemo-radiation therapy using pencil beam scanning proton therapy. J Neurooncol 2015;121:389–397.25362544, WeberDC, AresC, MalyapaR, Tumor control and qol outcomes of very young children with atypical teratoid/rhabdoid tumor treated with focal only chemo-radiation therapy using pencil beam scanning proton therapy. J Neurooncol 2015;121:389–397.25362544

  • (TaylorCW, WangZ, MacaulayE, Exposure of the heart in breast cancer radiation therapy: A systematic review of heart doses published during 2003 to 2013. Int J Radiat Oncol Biol Phys 2015; 93:845–853.26530753)

    TaylorCW, WangZ, MacaulayE,

    TaylorCW, WangZ, MacaulayE, Exposure of the heart in breast cancer radiation therapy: A systematic review of heart doses published during 2003 to 2013. Int J Radiat Oncol Biol Phys 2015; 93:845–853.26530753, TaylorCW, WangZ, MacaulayE, Exposure of the heart in breast cancer radiation therapy: A systematic review of heart doses published during 2003 to 2013. Int J Radiat Oncol Biol Phys 2015; 93:845–853.26530753

  • Straub (2015)

    1985

    J Cancer Res Clin Oncol, 141

  • Lin (2012)

    e345

    Int J Radiat Oncol Biol Phys, 83

  • O. Gjyshi, T. Xu, A. Elhammali, D. Boyce-Fappiano, S. Chun, S. Gandhi, Percy Lee, Aileen Chen, Steven Lin, Joe Chang, A. Tsao, C. Gay, X. Zhu, Xiaodong Zhang, J. Heymach, F. Fossella, Charles Lu, Q. Nguyen, Z. Liao (2020)

    Toxicity and Survival After Intensity-Modulated Proton Therapy Versus Passive Scattering Proton Therapy for NSCLC.

    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

  • P. Romesser, O. Cahlon, E. Scher, Ying Zhou, S. Berry, A. Rybkin, K. Sine, Shikui Tang, E. Sherman, R. Wong, N. Lee (2016)

    Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation.

    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 118 2

  • Charlie Pan, Brian Kavanagh, Laura Dawson, X. Li, Shiva Das, M. Miften, Randall Haken (2010)

    Radiation-associated liver injury.

    International journal of radiation oncology, biology, physics, 76 3 Suppl

  • (VenkatesuluBP, MallickS, LinSH, A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors. Crit Rev Oncol Hematol 2018;123:42–51.29482778)

    VenkatesuluBP, MallickS, LinSH,

    VenkatesuluBP, MallickS, LinSH, A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors. Crit Rev Oncol Hematol 2018;123:42–51.29482778, VenkatesuluBP, MallickS, LinSH, A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors. Crit Rev Oncol Hematol 2018;123:42–51.29482778

  • Mendenhall (2014)

    596

    Int J Radiat Oncol Biol Phys, 88

  • (FangP, MickR, DevilleC, A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancer. Cancer 2015;121:1118–1127.25423899)

    FangP, MickR, DevilleC,

    FangP, MickR, DevilleC, A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancer. Cancer 2015;121:1118–1127.25423899, FangP, MickR, DevilleC, A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancer. Cancer 2015;121:1118–1127.25423899

  • V. Verma, C. Shah, M. Mehta (2016)

    Clinical Outcomes and Toxicity of Proton Radiotherapy for Breast Cancer.

    Clinical breast cancer, 16 3

  • S. Liauw, P. Connell, R. Weichselbaum (2013)

    New Paradigms and Future Challenges in Radiation Oncology: An Update of Biological Targets and Technology

    Science Translational Medicine, 5

  • Kamran (2019)

    509

    Prostate Cancer Prostatic Dis, 22

  • Yeona Cho, Sangjoon Park, H. Byun, C. Lee, Jaeho Cho, M. Hong, H. Kim, B. Cho, Sinae Kim, Juyoung Park, H. Yoon (2019)

    Impact of Treatment-Related Lymphopenia on Immunotherapy for Advanced Non-Small Cell Lung Cancer.

    International journal of radiation oncology, biology, physics

  • (StickLB, YuJ, MaraldoMV, Joint estimation of cardiac toxicity and recurrence risks after comprehensive nodal photon versus proton therapy for breast cancer. Int J Radiat Oncol Biol Phys 2017;97:754–761.28244411)

    StickLB, YuJ, MaraldoMV,

    StickLB, YuJ, MaraldoMV, Joint estimation of cardiac toxicity and recurrence risks after comprehensive nodal photon versus proton therapy for breast cancer. Int J Radiat Oncol Biol Phys 2017;97:754–761.28244411, StickLB, YuJ, MaraldoMV, Joint estimation of cardiac toxicity and recurrence risks after comprehensive nodal photon versus proton therapy for breast cancer. Int J Radiat Oncol Biol Phys 2017;97:754–761.28244411

  • Joe Chang, Xiaodong Zhang, A. Knopf, Heng Li, S. Mori, L. Dong, Hsiao-Ming Lu, Wei Liu, S. Badiyan, S. Both, A. Meijers, Liyong Lin, S. Flampouri, Zuofeng Li, K. Umegaki, C. Simone, X. Zhu (2017)

    Consensus Guidelines for Implementing Pencil-Beam Scanning Proton Therapy for Thoracic Malignancies on Behalf of the PTCOG Thoracic and Lymphoma Subcommittee.

    International journal of radiation oncology, biology, physics, 99 1

  • Antony Lomax (2008)

    Intensity modulated proton therapy and its sensitivity to treatment uncertainties 2: the potential effects of inter-fraction and inter-field motions

    Physics in Medicine & Biology, 53

  • (ChuongMD, HallemeierCL, JabbourSK, Improving outcomes for esophageal cancer using proton beam therapy. Int J Radiat Oncol Biol Phys 2016;95:488–497.27084662)

    ChuongMD, HallemeierCL, JabbourSK,

    ChuongMD, HallemeierCL, JabbourSK, Improving outcomes for esophageal cancer using proton beam therapy. Int J Radiat Oncol Biol Phys 2016;95:488–497.27084662, ChuongMD, HallemeierCL, JabbourSK, Improving outcomes for esophageal cancer using proton beam therapy. Int J Radiat Oncol Biol Phys 2016;95:488–497.27084662

  • Chang (2016)

    505

    Int J Radiat Oncol Biol Phys, 95

  • Ahmed (2018)

    2166

    Cancer Res, 78

  • W. Koh, Wenying Pan, Charles Gawad, H. Fan, G. Kerchner, T. Wyss-Coray, Y. Blumenfeld, Y. El‐Sayed, S. Quake (2014)

    Noninvasive in vivo monitoring of tissue-specific global gene expression in humans

    Proceedings of the National Academy of Sciences, 111

  • (ShuryakI, FornaceAJJr., DattaK, Scaling human cancer risks from low LET to high LET when dose-effect relationships are complex. Radiat Res 2017;187:476–482.28218889)

    ShuryakI, FornaceAJJr., DattaK,

    ShuryakI, FornaceAJJr., DattaK, Scaling human cancer risks from low LET to high LET when dose-effect relationships are complex. Radiat Res 2017;187:476–482.28218889, ShuryakI, FornaceAJJr., DattaK, Scaling human cancer risks from low LET to high LET when dose-effect relationships are complex. Radiat Res 2017;187:476–482.28218889

  • (LiamsuwanT, UeharaS, EmfietzoglouD, Physical and biophysical properties of proton tracks of energies 1 keV to 300 MeV in water. Int J Radiat Biol 2011;87:141–160.21281230)

    LiamsuwanT, UeharaS, EmfietzoglouD,

    LiamsuwanT, UeharaS, EmfietzoglouD, Physical and biophysical properties of proton tracks of energies 1 keV to 300 MeV in water. Int J Radiat Biol 2011;87:141–160.21281230, LiamsuwanT, UeharaS, EmfietzoglouD, Physical and biophysical properties of proton tracks of energies 1 keV to 300 MeV in water. Int J Radiat Biol 2011;87:141–160.21281230

  • (TommasinoF, DuranteM, D’AvinoV, Model-based approach for quantitative estimates of skin, heart, and lung toxicity risk for left-side photon and proton irradiation after breast-conserving surgery. Acta Oncol 2017;56:730–736.28281862)

    TommasinoF, DuranteM, D?AvinoV,

    TommasinoF, DuranteM, D’AvinoV, Model-based approach for quantitative estimates of skin, heart, and lung toxicity risk for left-side photon and proton irradiation after breast-conserving surgery. Acta Oncol 2017;56:730–736.28281862, TommasinoF, DuranteM, D’AvinoV, Model-based approach for quantitative estimates of skin, heart, and lung toxicity risk for left-side photon and proton irradiation after breast-conserving surgery. Acta Oncol 2017;56:730–736.28281862

  • Bluethmann (2016)

    1029

    Cancer Epidemiol Biomarkers Prev, 25

  • (SioTT, LinHK, ShiQ, Intensity modulated proton therapy versus intensity modulated photon radiation therapy for oropharyngeal cancer: First comparative results of patient-reported outcomes. Int J Radiat Oncol Biol Phys 2016;95:1107–1114.27354125)

    SioTT, LinHK, ShiQ,

    SioTT, LinHK, ShiQ, Intensity modulated proton therapy versus intensity modulated photon radiation therapy for oropharyngeal cancer: First comparative results of patient-reported outcomes. Int J Radiat Oncol Biol Phys 2016;95:1107–1114.27354125, SioTT, LinHK, ShiQ, Intensity modulated proton therapy versus intensity modulated photon radiation therapy for oropharyngeal cancer: First comparative results of patient-reported outcomes. Int J Radiat Oncol Biol Phys 2016;95:1107–1114.27354125

  • J. Bekelman, Hien Lu, S. Pugh, Kaysee Baker, C. Berg, Amy Gonzalez, L. Braunstein, W. Bosch, Cynthia Chauhan, S. Ellenberg, L. Fang, G. Freedman, E. Hahn, B. Haffty, Atif Khan, R. Jimenez, C. Kesslering, B. Ky, Choonsik Lee, Hsiao-Ming Lu, M. Mishra, Daniel Mullins, R. Mutter, S. Nagda, M. Pankuch, S. Powell, F. Prior, K. Schupak, A. Taghian, J. Wilkinson, S. MacDonald, O. Cahlon, Radiotherapy Comparative (2019)

    Pragmatic randomised clinical trial of proton versus photon therapy for patients with non-metastatic breast cancer: the Radiotherapy Comparative Effectiveness (RadComp) Consortium trial protocol

    BMJ Open, 9

  • Long-Xiao Wei, Haijiao Shang, F. Jin, Yuenan Wang (2020)

    Mitigation of the Interplay Effects of Combining 4D Robust With Layer Repainting Techniques in Proton-Based SBRT for Patients With Early-Stage Non-small Cell Lung Cancer

    Frontiers in Oncology, 10

  • Mizumoto (2011)

    1039

    Int J Radiat Oncol Biol Phys, 81

  • (LiuW, ZhangX, LiY, Robust optimization of intensity modulated proton therapy. Med Phys 2012;39:1079–1091.22320818)

    LiuW, ZhangX, LiY,

    LiuW, ZhangX, LiY, Robust optimization of intensity modulated proton therapy. Med Phys 2012;39:1079–1091.22320818, LiuW, ZhangX, LiY, Robust optimization of intensity modulated proton therapy. Med Phys 2012;39:1079–1091.22320818

  • (GrassbergerC, HongTS, HatoT, Differential association between circulating lymphocyte populations with outcome after radiation therapy in subtypes of liver cancer. Int J Radiat Oncol Biol Phys 2018;101:1222–1225.29859792)

    GrassbergerC, HongTS, HatoT,

    GrassbergerC, HongTS, HatoT, Differential association between circulating lymphocyte populations with outcome after radiation therapy in subtypes of liver cancer. Int J Radiat Oncol Biol Phys 2018;101:1222–1225.29859792, GrassbergerC, HongTS, HatoT, Differential association between circulating lymphocyte populations with outcome after radiation therapy in subtypes of liver cancer. Int J Radiat Oncol Biol Phys 2018;101:1222–1225.29859792

  • P. Blanchard, A. Garden, G. Gunn, D. Rosenthal, W. Morrison, Mike Hernandez, J. Crutison, Jack Lee, R. Ye, C. Fuller, A. Mohamed, K. Hutcheson, E. Holliday, N. Thaker, E. Sturgis, M. Kies, X. Zhu, R. Mohan, S. Frank (2016)

    Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysis.

    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 120 1

  • B. Hoppe, J. Michalski, N. Mendenhall, C. Morris, R. Henderson, R. Nichols, W. Mendenhall, C. Williams, M. Regan, J. Chipman, Catrina Crociani, H. Sandler, M. Sanda, D. Hamstra (2014)

    Comparative effectiveness study of patient‐reported outcomes after proton therapy or intensity‐modulated radiotherapy for prostate cancer

    Cancer, 120

  • Prasanna (2012)

    35

    Transl Cancer Res, 1

  • (ThariatJ, Hannoun-LeviJM, Sun MyintA, Past, present, and future of radiotherapy for the benefit of patients. Nat Rev Clin Oncol 2013;10:52–60.23183635)

    ThariatJ, Hannoun-LeviJM, Sun MyintA,

    ThariatJ, Hannoun-LeviJM, Sun MyintA, Past, present, and future of radiotherapy for the benefit of patients. Nat Rev Clin Oncol 2013;10:52–60.23183635, ThariatJ, Hannoun-LeviJM, Sun MyintA, Past, present, and future of radiotherapy for the benefit of patients. Nat Rev Clin Oncol 2013;10:52–60.23183635

  • E. Bahn, J. Bauer, S. Harrabi, K. Herfarth, J. Debus, M. Alber (2020)

    Late contrast enhancing brain lesions in proton treated low-grade glioma patients: clinical evidence for increased periventricular sensitivity and variable RBE.

    International journal of radiation oncology, biology, physics

  • S. MacDonald, S. Patel, S. Hickey, M. Specht, S. Isakoff, M. Gadd, Barbara Smith, B. Yeap, J. Adams, T. Delaney, H. Kooy, Hsiao-Ming Lu, A. Taghian (2013)

    Proton therapy for breast cancer after mastectomy: early outcomes of a prospective clinical trial.

    International journal of radiation oncology, biology, physics, 86 3

  • Mohan (2018)

    816

    Int J Radiat Oncol Biol Phys, 100

  • Carolyn Taylor, Zhe Wang, Elizabeth Macaulay, R. Jagsi, F. Duane, S. Darby (2015)

    Exposure of the Heart in Breast Cancer Radiation Therapy: A Systematic Review of Heart Doses Published During 2003 to 2013.

    International journal of radiation oncology, biology, physics, 93 4

  • (GjyshiO, XuT, ElhammaliA, Toxicity and survival after intensity-modulated proton therapy versus passive scattering proton therapy for NSCLC. J Thorac Oncol 2021;16:269–277.33198942)

    GjyshiO, XuT, ElhammaliA,

    GjyshiO, XuT, ElhammaliA, Toxicity and survival after intensity-modulated proton therapy versus passive scattering proton therapy for NSCLC. J Thorac Oncol 2021;16:269–277.33198942, GjyshiO, XuT, ElhammaliA, Toxicity and survival after intensity-modulated proton therapy versus passive scattering proton therapy for NSCLC. J Thorac Oncol 2021;16:269–277.33198942

  • Taylor (2015)

    845

    Int J Radiat Oncol Biol Phys, 93

  • (HirayamaS, MatsuuraT, UedaH, An analytical dose-averaged LET calculation algorithm considering the off-axis LET enhancement by secondary protons for spot-scanning proton therapy. Med Phys 2018;45:3404–3416.29788552)

    HirayamaS, MatsuuraT, UedaH,

    HirayamaS, MatsuuraT, UedaH, An analytical dose-averaged LET calculation algorithm considering the off-axis LET enhancement by secondary protons for spot-scanning proton therapy. Med Phys 2018;45:3404–3416.29788552, HirayamaS, MatsuuraT, UedaH, An analytical dose-averaged LET calculation algorithm considering the off-axis LET enhancement by secondary protons for spot-scanning proton therapy. Med Phys 2018;45:3404–3416.29788552

  • (GrassbergerC, DowdellS, LomaxA, Motion interplay as a function of patient parameters and spot size in spot scanning proton therapy for lung cancer. Int J Radiat Oncol Biol Phys 2013;86: 380–386.23462423)

    GrassbergerC, DowdellS, LomaxA,

    GrassbergerC, DowdellS, LomaxA, Motion interplay as a function of patient parameters and spot size in spot scanning proton therapy for lung cancer. Int J Radiat Oncol Biol Phys 2013;86: 380–386.23462423, GrassbergerC, DowdellS, LomaxA, Motion interplay as a function of patient parameters and spot size in spot scanning proton therapy for lung cancer. Int J Radiat Oncol Biol Phys 2013;86: 380–386.23462423

  • Horn (2016)

    98

    Cancer Radiother, 20

  • G. Ntentas, K. Dědečková, M. Andrlík, M. Aznar, B. George, J. Kubeš, S. Darby, D. Cutter (2019)

    Clinical Intensity Modulated Proton Therapy for Hodgkin Lymphoma: Which Patients Benefit the Most?

    Practical Radiation Oncology, 9

  • Basch (2014)

    Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)

    J Natl Cancer Inst, 106

  • Gerelchuluun (2011)

    57

    Int J Radiat Biol, 87

  • MacDonald (2013)

    484

    Int J Radiat Oncol Biol Phys, 86

  • (LiauwSL, ConnellPP, WeichselbaumRR. New paradigms and future challenges in radiation oncology: An update of biological targets and technology. Sci Transl Med 2013;5:173sr2.)

    LiauwSL, ConnellPP, WeichselbaumRR. New paradigms and future challenges in radiation oncology: An update of biological targets and technology. Sci Transl Med

    LiauwSL, ConnellPP, WeichselbaumRR. New paradigms and future challenges in radiation oncology: An update of biological targets and technology. Sci Transl Med 2013;5:173sr2., LiauwSL, ConnellPP, WeichselbaumRR. New paradigms and future challenges in radiation oncology: An update of biological targets and technology. Sci Transl Med 2013;5:173sr2.

  • (MohanR, HeldKD, StoryMD, GrosshansD, CapalaJ. Proceedings of the National Cancer Institute workshop on charged particle therapy. Int J Radiat Oncol Biol Phys 2018;100:816–831.29485053)

    MohanR, HeldKD, StoryMD, GrosshansD, CapalaJ. Proceedings of the National Cancer Institute workshop on charged particle therapy. Int J Radiat Oncol Biol Phys

    MohanR, HeldKD, StoryMD, GrosshansD, CapalaJ. Proceedings of the National Cancer Institute workshop on charged particle therapy. Int J Radiat Oncol Biol Phys 2018;100:816–831.29485053, MohanR, HeldKD, StoryMD, GrosshansD, CapalaJ. Proceedings of the National Cancer Institute workshop on charged particle therapy. Int J Radiat Oncol Biol Phys 2018;100:816–831.29485053

  • Atun (2015)

    1153

    Lancet Oncol, 16

  • J. Mirsch, F. Tommasino, Antonia Frohns, S. Conrad, M. Durante, M. Scholz, T. Friedrich, M. Löbrich (2015)

    Direct measurement of the 3-dimensional DNA lesion distribution induced by energetic charged particles in a mouse model tissue

    Proceedings of the National Academy of Sciences, 112

  • N. Mendenhall, B. Hoppe, R. Nichols, W. Mendenhall, C. Morris, Zuofeng Li, Z. Su, C. Williams, Joseph Costa, R. Henderson (2014)

    Five-year outcomes from 3 prospective trials of image-guided proton therapy for prostate cancer.

    International journal of radiation oncology, biology, physics, 88 3

  • (EatonBR, YockT. The use of proton therapy in the treatment of benign or low-grade pediatric brain tumors. Cancer J 2014;20:403–408.25415686)

    EatonBR, YockT. The use of proton therapy in the treatment of benign or low-grade pediatric brain tumors. Cancer J

    EatonBR, YockT. The use of proton therapy in the treatment of benign or low-grade pediatric brain tumors. Cancer J 2014;20:403–408.25415686, EatonBR, YockT. The use of proton therapy in the treatment of benign or low-grade pediatric brain tumors. Cancer J 2014;20:403–408.25415686

  • Thariat (2013)

    52

    Nat Rev Clin Oncol, 10

  • S. McClelland, J. Jaboin, G. Watson, R. Zellars (2019)

    Is the side effect profile of protons really safer than photons for intracranial disease?

    Clinical Neurology and Neurosurgery, 176

  • (NantavithyaC, GomezDR, WeiX, Phase 2 study of stereotactic body radiation therapy and stereotactic body proton therapy for high-risk, medically inoperable, early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2018;101:558–563.29680255)

    NantavithyaC, GomezDR, WeiX,

    NantavithyaC, GomezDR, WeiX, Phase 2 study of stereotactic body radiation therapy and stereotactic body proton therapy for high-risk, medically inoperable, early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2018;101:558–563.29680255, NantavithyaC, GomezDR, WeiX, Phase 2 study of stereotactic body radiation therapy and stereotactic body proton therapy for high-risk, medically inoperable, early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2018;101:558–563.29680255

  • Jadon (2014)

    185

    Clin Oncol (R Coll Radiol), 26

  • Blanchard (2016)

    48

    Radiother Oncol, 120

  • (KabarritiR, BrodinNP, AhmedS, Origin of locoregional recurrences after definitive intensity-modulated radiation therapy (IMRT) for laryngeal cancer determined based on follow-up PET/CT imaging. Cureus 2019;11:e3856.30899607)

    KabarritiR, BrodinNP, AhmedS,

    KabarritiR, BrodinNP, AhmedS, Origin of locoregional recurrences after definitive intensity-modulated radiation therapy (IMRT) for laryngeal cancer determined based on follow-up PET/CT imaging. Cureus 2019;11:e3856.30899607, KabarritiR, BrodinNP, AhmedS, Origin of locoregional recurrences after definitive intensity-modulated radiation therapy (IMRT) for laryngeal cancer determined based on follow-up PET/CT imaging. Cureus 2019;11:e3856.30899607

  • (BlanchardP, GardenAS, GunnGB, Intensity-modulated proton beam therapy (impt) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - a case matched analysis. Radiother Oncol 2016;120:48–55.27342249)

    BlanchardP, GardenAS, GunnGB,

    BlanchardP, GardenAS, GunnGB, Intensity-modulated proton beam therapy (impt) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - a case matched analysis. Radiother Oncol 2016;120:48–55.27342249, BlanchardP, GardenAS, GunnGB, Intensity-modulated proton beam therapy (impt) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - a case matched analysis. Radiother Oncol 2016;120:48–55.27342249

  • R. Jadon, C. Pembroke, C. Hanna, N. Palaniappan, M. Evans, A. Cleves, J. Staffurth (2014)

    A systematic review of organ motion and image-guided strategies in external beam radiotherapy for cervical cancer.

    Clinical oncology (Royal College of Radiologists (Great Britain)), 26 4

  • (St JamesS, GrassbergerC, LuHM. Considerations when treating lung cancer with passive scatter or active scanning proton therapy. Transl Lung Cancer Res 2018;7:210–215.29876321)

    St JamesS, GrassbergerC, LuHM. Considerations when treating lung cancer with passive scatter or active scanning proton therapy. Transl Lung Cancer Res

    St JamesS, GrassbergerC, LuHM. Considerations when treating lung cancer with passive scatter or active scanning proton therapy. Transl Lung Cancer Res 2018;7:210–215.29876321, St JamesS, GrassbergerC, LuHM. Considerations when treating lung cancer with passive scatter or active scanning proton therapy. Transl Lung Cancer Res 2018;7:210–215.29876321

  • (HornS, Fournier-BidozN, PerninV, Comparison of passive-beam proton therapy, helical tomotherapy and 3D conformal radiation therapy in Hodgkin’s lymphoma female patients receiving involved-field or involved site radiation therapy. Cancer Radiother 2016;20:98–103.26992750)

    HornS, Fournier-BidozN, PerninV,

    HornS, Fournier-BidozN, PerninV, Comparison of passive-beam proton therapy, helical tomotherapy and 3D conformal radiation therapy in Hodgkin’s lymphoma female patients receiving involved-field or involved site radiation therapy. Cancer Radiother 2016;20:98–103.26992750, HornS, Fournier-BidozN, PerninV, Comparison of passive-beam proton therapy, helical tomotherapy and 3D conformal radiation therapy in Hodgkin’s lymphoma female patients receiving involved-field or involved site radiation therapy. Cancer Radiother 2016;20:98–103.26992750

  • N. Ohri, A. Dicker, T. Showalter (2012)

    Late toxicity rates following definitive radiotherapy for prostate cancer.

    The Canadian journal of urology, 19 4

  • (MeskoS, GomezD. Proton therapy in non-small cell lung cancer. Curr Treat Options Oncol 2018;19:76.30483900)

    MeskoS, GomezD. Proton therapy in non-small cell lung cancer. Curr Treat Options Oncol

    MeskoS, GomezD. Proton therapy in non-small cell lung cancer. Curr Treat Options Oncol 2018;19:76.30483900, MeskoS, GomezD. Proton therapy in non-small cell lung cancer. Curr Treat Options Oncol 2018;19:76.30483900

  • Nantavithya (2018)

    558

    Int J Radiat Oncol Biol Phys, 101

  • (HammiA, PaganettiH, GrassbergerC. 4D blood flow model for dose calculation to circulating blood and lymphocytes. Phys Med Biol 2020;65:055008.)

    HammiA, PaganettiH, GrassbergerC. 4D blood flow model for dose calculation to circulating blood and lymphocytes. Phys Med Biol

    HammiA, PaganettiH, GrassbergerC. 4D blood flow model for dose calculation to circulating blood and lymphocytes. Phys Med Biol 2020;65:055008., HammiA, PaganettiH, GrassbergerC. 4D blood flow model for dose calculation to circulating blood and lymphocytes. Phys Med Biol 2020;65:055008.

  • Oden (2017)

    810

    Med Phys, 44

  • (GirdhaniS, SachsR, HlatkyL. Biological effects of proton radiation: What we know and don’t know. Radiat Res 2013;179: 257–272.23373900)

    GirdhaniS, SachsR, HlatkyL. Biological effects of proton radiation: What we know and don?t know. Radiat Res

    GirdhaniS, SachsR, HlatkyL. Biological effects of proton radiation: What we know and don’t know. Radiat Res 2013;179: 257–272.23373900, GirdhaniS, SachsR, HlatkyL. Biological effects of proton radiation: What we know and don’t know. Radiat Res 2013;179: 257–272.23373900

  • (AhmedMM, ColemanCN, MendoncaM, Workshop report for cancer research: Defining the shades of Gy: Utilizing the biological consequences of radiotherapy in the development of new treatment approaches-meeting viewpoint. Cancer Res 2018;78: 2166–2170.29686020)

    AhmedMM, ColemanCN, MendoncaM,

    AhmedMM, ColemanCN, MendoncaM, Workshop report for cancer research: Defining the shades of Gy: Utilizing the biological consequences of radiotherapy in the development of new treatment approaches-meeting viewpoint. Cancer Res 2018;78: 2166–2170.29686020, AhmedMM, ColemanCN, MendoncaM, Workshop report for cancer research: Defining the shades of Gy: Utilizing the biological consequences of radiotherapy in the development of new treatment approaches-meeting viewpoint. Cancer Res 2018;78: 2166–2170.29686020

  • B. Eaton, T. Yock (2014)

    The Use of Proton Therapy in the Treatment of Benign or Low-Grade Pediatric Brain Tumors

    The Cancer Journal, 20

  • C. Veiga, G. Janssens, C. Teng, T. Baudier, L. Hotoiu, J. McClelland, G. Royle, Liyong Lin, L. Yin, J. Metz, T. Solberg, Z. Tochner, C. Simone, J. Mcdonough, B. Teo (2016)

    First Clinical Investigation of Cone Beam Computed Tomography and Deformable Registration for Adaptive Proton Therapy for Lung Cancer.

    International journal of radiation oncology, biology, physics, 95 1

  • (RomesserPB, CahlonO, ScherE, Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation. Radiother Oncol 2016;118: 286–292.26867969)

    RomesserPB, CahlonO, ScherE,

    RomesserPB, CahlonO, ScherE, Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation. Radiother Oncol 2016;118: 286–292.26867969, RomesserPB, CahlonO, ScherE, Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation. Radiother Oncol 2016;118: 286–292.26867969

  • Indelicato (2014)

    1298

    Acta Oncol, 53

  • H. Willers, Antiño Allen, D. Grosshans, S. McMahon, C. Neubeck, C. Wiese, B. Vikram (2018)

    Toward A variable RBE for proton beam therapy.

    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 128 1

  • Lomax (2008)

    1043

    Phys Med Biol, 53

  • Leeman (2017)

    e254

    Lancet Oncol, 18

  • A. Jakobi, K. Stützer, A. Bandurska-Luque, S. Löck, R. Haase, L. Wack, D. Mönnich, D. Thorwarth, D. Perez, A. Lühr, D. Zips, M. Krause, M. Baumann, R. Perrin, C. Richter (2015)

    NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy

    Acta Oncologica, 54

  • (HoppeBS, MichalskiJM, MendenhallNP, Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer. Cancer 2014;120:1076–1082.24382757)

    HoppeBS, MichalskiJM, MendenhallNP,

    HoppeBS, MichalskiJM, MendenhallNP, Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer. Cancer 2014;120:1076–1082.24382757, HoppeBS, MichalskiJM, MendenhallNP, Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer. Cancer 2014;120:1076–1082.24382757

Copyright
Published by Elsevier Inc.
eISSN
1879-355X
DOI
10.1016/j.ijrobp.2021.02.043
pmid
33640423
Publisher site
See Article on Publisher Site

Abstract

Journal

International journal of radiation oncology, biology, physicsPubmed

Published: Sep 23, 2021

There are no references for this article.